
==== Front
Front Cell Dev Biol
Front Cell Dev Biol
Front. Cell Dev. Biol.
Frontiers in Cell and Developmental Biology
2296-634X
Frontiers Media S.A.

10.3389/fcell.2021.728576
Cell and Developmental Biology
Review
The Multifaceted Roles of Proline in Cell Behavior
Patriarca Eduardo J.

Cermola Federica

D’Aniello Cristina

Fico Annalisa

Guardiola Ombretta

De Cesare Dario

Minchiotti Gabriella *

Stem Cell Fate Laboratory, Institute of Genetics and Biophysics “A. Buzzati Traverso”, Consiglio Nazionale delle Ricerche, Naples, Italy
Edited by: Andrei Surguchov, University of Kansas Medical Center, United States

Reviewed by: Irina G. Sourgoutcheva, University of Kansas Medical Center, United States; Dwijendra K. Gupta, Jai Prakash Vishwavidyalaya, India

*Correspondence: Gabriella Minchiotti, gabriella.minchiotti@igb.cnr.it
This article was submitted to Cellular Biochemistry, a section of the journal Frontiers in Cell and Developmental Biology

12 8 2021
2021
9 72857621 6 2021
23 7 2021
Copyright © 2021 Patriarca, Cermola, D’Aniello, Fico, Guardiola, De Cesare and Minchiotti.
2021
Patriarca, Cermola, D’Aniello, Fico, Guardiola, De Cesare and Minchiotti
https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Herein, we review the multifaceted roles of proline in cell biology. This peculiar cyclic imino acid is: (i) A main precursor of extracellular collagens (the most abundant human proteins), antimicrobial peptides (involved in innate immunity), salivary proteins (astringency, teeth health) and cornifins (skin permeability); (ii) an energy source for pathogenic bacteria, protozoan parasites, and metastatic cancer cells, which engage in extracellular-protein degradation to invade their host; (iii) an antistress molecule (an osmolyte and chemical chaperone) helpful against various potential harms (UV radiation, drought/salinity, heavy metals, reactive oxygen species); (iv) a neural metabotoxin associated with schizophrenia; (v) a modulator of cell signaling pathways such as the amino acid stress response and extracellular signal-related kinase pathway; (vi) an epigenetic modifier able to promote DNA and histone hypermethylation; (vii) an inducer of proliferation of stem and tumor cells; and (viii) a modulator of cell morphology and migration/invasiveness. We highlight how proline metabolism impacts beneficial tissue regeneration, but also contributes to the progression of devastating pathologies such as fibrosis and metastatic cancer.

proline metabolism
cell plasticity
extracellular proteins
energy source
antistress activity
neural toxicity
signaling modulators
metabolism
Associazione Italiana per la Ricerca sul Cancro10.13039/501100005010Ministero dell’Istruzione, dell’Università e della Ricerca10.13039/501100003407
==== Body
Introduction

In 1900, Richard M. Willstätter reported the synthesis of (S)-pyrrolidine-2-carboxylic acid, better known as L-Pro. Town (1928) reported the purification of L-Pro from gliadin proteins, and Levine (1959) reported that nitrous acid destroys all amino acids apart from L-Pro in hydrolyzed gelatins, and highlighted its unusual structure. L-Pro is a small (115.13 g/mol), cyclic, non-polar, non-toxic, odorless, sweet-tasting imino acid, with unique physicochemical proprieties and numerous biotechnological applications (Figure 1). For instance, acting as an enantioselective organocatalyst, L-Pro makes possible the synthesis of therapeutically active enantiopure drugs (Table 1). Moreover, acting as a chemical chaperone, L-Pro can prevent protein aggregation/fibrillation, and is therefore used to stabilize monoclonal antibodies, to generate protein crystals (Table 1), and for the cryopreservation of biological specimens, including stem cells and oocytes (Table 1). Due to its peculiar cyclic structure, its metabolism relies on specific enzymes. For instance, in mammalian cells L-Pro is synthesized from L-glutamate in a two-step intramitochondrial process catalyzed by aldehyde dehydrogenase 18 family member A1 (ALDH18A1) and pyrroline-5-carboxylate reductase 1 (PYCR1) enzymes (Figure 1), whereas it is oxidized to L-glutamate in a two-step intramitochondrial process catalyzed by proline dehydrogenase (PRODH) and pyrroline-5-carboxylate dehydrogenase (P5CDH) enzymes (Figure 1).

FIGURE 1 Proline structure, uses, biosynthesis and degradation/oxidation. Chirality of pyrrolidine-2-carboxylic acid (top), known as proline (CAS: 147-85-3, EC: 205-702-2, CHEBI: 17203, HMDB0000162, MW = 115.13 g/mol). Of the two enantiomers (L and D) living cells metabolize predominantly the L-proline enantiomer (top). Proline is an organocatalyst used to synthesize enantiopure drugs (middle top). Proline is also a potent chemical chaperone able to stabilize proteins in their natural conformation and thus, it is used to cryopreserve living cells/organisms (middle bottom). Due to its pyrrolidine ring structure, the enzymes involved in de novo L-proline biosynthesis, namely aldehyde dehydrogenase 18 family member A1 (ALDH18A1) and pyrroline-5-carboxylate reductase 1 (PYCR1), as well as the enzymes involved in L-proline oxidation, namely proline dehydrogenase (PRODH) and the pyrroline-5-carboxylate dehydrogenase (P5CDH), are highly specific (bottom).

TABLE 1 Proline in drug synthesis, protein stabilization and cryopreservation.

Enantioselective organocatalysis1	
Compound synthesized	Type of chemical reaction	References	
Prostaglandin PGF2alpha	Corey’s synthesis	Coulthard et al. (2012)	
Pyrans, and thiopyrans	Methylene ketones and α,β-unsaturated nitriles	Elnagdi and Al-Hokbany (2012)	
(R)-4-(4-Methoxy-phenylamino)-6-methyl-heptan-2-one	Ketones, aldehydes and Meldrum’s acid	List and Castello (2001)	
Oxazolidinones	Asymmetric aldol reaction	List et al. (2004)	
Delta(1)(2)-prostaglandin J(3)	–	Pelss et al. (2018)	
–	Hajos–Parrish–Eder–Sauer–Wiechert (HPESW) reaction	Rance and Khlobystov (2014)	
Erythromcin 1	Stereospecific aldolization	Agami et al. (1987)	
–	Michael addition of malonate anions to enones and enals	Yamaguchi et al. (1996)	
Protein stabilization2	
Biological sample	Stabilizing medium		
Insulin	L-Proline (0.05–0.25 M)	Choudhary et al. (2015)	
Insulin and lysozyme	L-Proline/sorbitol	Choudhary et al. (2016)	
Antibodies solutions (mAb)	L-Proline (up to 1.3 M)	Hung et al. (2018)	
Huntingtin (polyQ tracts)	L-Proline	Ignatova and Gierasch (2006)	
Lysozyme, xylose isomerase, P5CDH	L-Proline (2–3 M) and protein-crystallization solution	Pemberton et al. (2012)	
Lysozyme	L-Proline (1.5–4.0 M)	Samuel et al. (1997), Samuel et al. (2000)	
Lactate dehydrogenase	L-Proline (up to 4.0 M)	Wang and Bolen (1996)	
Cryopreservation/vitrification3	
Specimen	Freezing medium		
Human mesenchymal stem cells (hMSCs)	L-Proline, methylcellulose, ectoin	Freimark et al. (2011)	
Human endothelial cells	L-Proline	Sun et al. (2012)	
Ram sperm	L-Proline	Sanchez-Partida et al. (1998)	
Mammalian oocytes	L-Proline/ethylene glycol/DMSO	Zhang et al. (2016a, b)	
Donkey semen	L-Proline	Li et al. (2021)	
Mice oocytes	L-Proline oligomers (L-Pron)	Qin et al. (2020), Treleaven et al. (2021)	
Lactic acid bacteria	L-Proline/glycerol	Qiao et al. (2018)	
Vesicles of sarcoplasmic reticulum from lobster muscle	L-Proline (more effective than glycerol or DMSO)	Rudolph and Crowe (1985)	
Applications in: 1pharmaceutical industry, 2pharmacological therapy, and 3biomedical research, regenerative medicine.

Proline in Extracellular Matrix Production

L-Proline residues constitute nearly 6% of the human proteome, mainly concentrated in L-Pro-rich proteins, with up to 1 × 104 L-Pro-rich motifs/stretches occurring in 1.8 × 104 human proteins (Morgan and Rubenstein, 2013; Mandal et al., 2014). In addition to a high L-Pro content (up to 50% of total residues), L-Pro-rich peptides/proteins share extracellular localization (secreted proteins), a dedicated translation factor (EIF5A), and a requirement for timely L-Pro-tRNA loading (Doerfel et al., 2013; Gutierrez et al., 2013; Wu et al., 2020; Faundes et al., 2021). Free L-Pro is derived from dietary sources (animal collagens or vegetable extensins) or from de novo biosynthesis (Figure 1), which relies on mitochondrial generation of reduced nicotinamide adenine dinucleotide phosphate (NADPH) (Tran et al., 2021; Zhu et al., 2021). Why so many extracellular proteins are rich in L-Pro is a fascinating question; L-Pro residues destabilize α-helices and β-sheets protein secondary structures, enables turns and poly-Pro helices, and are major ‘disorder-promoting’ residues in intrinsically disordered proteins (Theillet et al., 2013; Alderson et al., 2018; Mateos et al., 2020).

Matrix Collagens

Collagens constitute ∼30% of total human proteins (Smith and Rennie, 2007), and are secreted by cells of CTs such as bone, cartilage, tendon, ligament, and interconnected fluid-filled CTs (Benias et al., 2018) that support and connects all other tissues (epithelial, muscular, etc.). Collagen synthesis is highly dependent on L-Pro availability (∼170 μM in plasma) (Psychogios et al., 2011), and inherited mutations in ALDH18A1 or PYCR1 (de novo L-Pro biosynthesis) are a cause of abnormal CT development (Table 2). Extrinsic (dietary) L-Pro is essential during adult life to preserve bone density in a mice model of osteoporosis (Nam et al., 2016), collagen deposition in rats, pigs, chickens and fish (Li and Wu, 2018; He et al., 2021), and L-Pro homeostasis in humans (Jaksic et al., 1990; Bertolo and Burrin, 2008).

TABLE 2 Diseases associated with defects in genes involved in the proline metabolism.

Process	Gene	Syndrome	*	OMIM	Phenotype	References	
Proline biosynthesis	ALDH18A1 (P5CS)	Cutis laxa 3	AD	616603	Wrinkled and thin skin, cataracts, joint hyperlaxity	Jukkola et al. (1998), Fischer-Zirnsak et al. (2015), Bhola et al. (2017)	
		Cutis laxa type IIIA	AR	219150	Growth retardation, poor postnatal growth,	de Barsy et al. (1968), Baumgartner et al. (2000), Bicknell et al. (2008), Skidmore et al. (2011), Fischer et al. (2014)	
		Spastic paraplegia 9A	AD	601162	Short stature, skeletal abnormalities, cataracts	Slavotinek et al. (1996), Seri et al. (1999), Coutelier et al. (2015), Panza et al. (2016)	
		Spastic paraplegia 9B	AR	616586	Short stature, delayed psychomotor development	Coutelier et al. (2015), Magini et al. (2019)	
	PYCR1 (P5CR1)	Cutis laxa, type IIB	AR	612940	Aged appearance, joint hyperextensibility, osteopenia	Guernsey et al. (2009), Reversade et al. (2009), Kretz et al. (2011)	
		Cutis laxa type IIIB	AR	614438	Growth retardation, cutis laxa, aged appearance	Reversade et al. (2009), Lin et al. (2011)	
	PYCR2 (P5CR2)	Leukodystrophy, hypomyelinating, 10	AR	616420	Poor overall growth, malformed ears, cerebral atrophy	Nakayama et al. (2015), Zaki et al. (2016), Patel et al. (2021)	
Proline degradation	PRODH	Hyperprolinemia, type I	AR	239500	Neurologic defects, mental retardation, schizophrenia	Campbell et al. (1997), Jacquet et al. (2002, 2003, 2005)	
		Schizophrenia susceptibility 4	AD	600850	Psychosis, hallucinations, delusions, erratic behavior	Karayiorgou et al. (1995), Yoon et al. (2016)	
	P5CDH (ALDH4A1)	Hyperprolinemia, type II	AR	239510	Recurrent seizures, mental retardation, epilepsy	Valle et al. (1974, 1976), Geraghty et al. (1998), Kaur et al. (2021)	
Proline transport	SLC6A20	Hyperglycinuria	AD	138500	Renal oxalate stones, renal colic	Scriver (1968), Greene et al. (1973), Broer et al. (2008)	
		Iminoglycinuria, digenic	AR, DR	242600	Hyperprolinuria, hyperhydroxyprolinuria	Tancredi et al. (1970)	
	SLC6A19 (B°AT1)	Hartnup disorder	AR	234500	Short stature, intermittent cerebellar ataxia, psychosis	Kleta et al. (2004), Seow et al. (2004)	
		Hyperglycinuria	AD	138500	Renal oxalate stones, renal colic	Scriver (1968), Greene et al. (1973), Broer et al. (2008)	
		Iminoglycinuria, digenic	AR, DR	242600	Hyperprolinuria, hyperhydroxyprolinuria	Tancredi et al. (1970)	
	SLC36A2 (PAT2)	Hyperglycinuria	AD	138500	Renal oxalate stones, renal colic	Scriver (1968), Greene et al. (1973), Broer et al. (2008)	
		Iminoglycinuria, digenic	AR, DR	242600	Hyperprolinuria, hyperhydroxyprolinuria	Tancredi et al. (1970)	
	SLC6A7 (PROT)	Unknown		606205	Unknown	Fremeau et al. (1992), Shafqat et al. (1995), Velaz-Faircloth et al. (1995)	
*Inheritance.
AD, autosomal dominant; AR, autosomal recessive; DR, digenic recessive.

Antimicrobial Peptides

L-Proline-rich antimicrobial peptides (PrAMPs), involved in innate immunity, are the first line of defense against infections (Graf and Wilson, 2019), and they contain up to 50% L-Pro residues, and are secreted by insects, crustaceans and mammals (Table 3; Mishra et al., 2018). Mechanistically, PrAMPs are channeled by the peptide antibiotic transporter SbmA into the bacterial cytoplasm (Mattiuzzo et al., 2007; Runti et al., 2013), where they bind ribosomal proteins and inhibit protein synthesis (Figure 2 and Table 3; Graf et al., 2017; Graf and Wilson, 2019; Baliga et al., 2021).

TABLE 3 Proline-rich antimicrobial peptides.

Peptide	Isolated from	Susceptible organism	Molecular mechanism	References	
Apidaecins (18–20 aa)	Apis mellifera lymph fluid	Antibacterial (Gram-) Human and plant pathogens	Protein translation inhibition -Trapping RF1 and RF2 -Blocks assembly of 50S	Casteels et al. (1989), Li et al. (2006), Krizsan et al. (2015), Chen et al. (2017), Florin et al. (2017), Matsumoto et al. (2017), Graf et al. (2018)	
Astacidins	Procambarus clarkii	Broad spectrum antimicrobial		Shi et al. (2014), Roncevic et al. (2020)	
Arasin 1 (37 aa)	Hyas araneus (spider crab)	Antibacterial		Stensvag et al. (2008)	
Bactenicins (5–7 kD)	Bovine neutrophils Sheep and goat leukocytes	Broad spectrum antimicrobial	Protein translation inhibition Binds 70S T. thermophilus and E. coli	Gennaro et al. (1989), Shamova et al. (1999), Benincasa et al. (2010), Mardirossian et al. (2014, 2018a), Gagnon et al. (2016), Seefeldt et al. (2016)	
BnPRP1 (35 aa–3.8 kD)	Brassica napus	Antibacterial (Gram+, Gram−) Broad spectrum antifungal		Cao et al. (2015)	
Cg-Prp (37 aa)	Crassostrea gigas (oyster)	Antibacterial		Gueguen et al. (2009)	
Dolphin Tur1 (32 aa)	Tursiops truncatus		Protein translation inhibition Binds ribosome	Mardirossian et al. (2018b)	
Drosocins (19 aa)	Drosophila Oregon	Antibacterial		Bulet et al. (1993)	
Formaecin (16 aa)	Myrmecia gulosa (red bull ant)	Antibacterial		Mackintosh et al. (1998)	
Metchlnikowin (26 aa)	Drosophila Oregon	Antibacterial (Gram+), antifungal		Levashina et al. (1995)	
Oncocins (19 aa)	Oncopeltus fasciatus	Antibacterial (Gram−)	Protein translation inhibition Binds exit tunnel of 70S E. coli	Knappe et al. (2010), Roy et al. (2015), Seefeldt et al. (2015)	
P1 to P11 (3–9.5 kD)	Rapana venosa hemolymph	Antibacterial (Gram+, Gram−)		Dolashka et al. (2011)	
Pr-39	Sus scrofa	Multidrug-resistant bacteria		Agerberth et al. (1991), Linde et al. (2001), Gennaro et al. (2002)	
Pyrrhocoricins	Pyrrhocoris apterus	Antibacterial (Gram−)	Protein translation Inhibition E. coli	Cociancich et al. (1994), Kragol et al. (2002), Taniguchi et al. (2016)	
AmAMP14	Antheraea mylita	Antibacterial, antifungal	Cell membrane damage, cell lysis	Chowdhury et al. (2021)	

FIGURE 2 Proline in extracellular matrix production. Proline is a crucial building block of antimicrobial peptides, salivary proteins, epidermal cornifins, interstitial collagens, and plant nodulins. These proteins are all rich in proline residues (with up to 50% of total amino acids) and are all secreted in the extracellular space. In addition to shape cell/tissue microenvironment/architecture (fibrillar collagens), proline-rich proteins contribute to innate immunity (antibiotic activity) by inhibiting bacterial protein synthesis (top left), to diet selection (astringency) by binding polyphenolic tannis (top right) and, to teeth health by inducing enamel mineralization and preventing bacterial attacks (top right), to selective permeation (barrier of water, O2) by nodulins in N2 fixing root nodules of leguminous plants (middle left), and by cornifins in skin (middle right), and to signaling mechanical forces (ECM stiffness). The accumulation of interstitial collagens leads to pathological fibrosis and occurs in different tumoral tissues (bottom right).

Salivary Proteins

Unstructured L-Pro-rich salivary proteins (PRPs) contain up to 40% L-Pro residues and account for ∼70% of total proteins in human saliva (Messana et al., 2015; Lorenzo-Pouso et al., 2018). The acinar cells of parotid and submandibular salivary glands synthesize and secrete acidic (aPRP) and basic (bPRP) proteins (Figure 2). While aPRPs bind calcium and protect the tooth surface, bPRPs bind polyphenols/tannins inducing the astringency sensation that influences diet selection (Canon et al., 2021; Dufourc, 2021). Since tannins induce ER stress and ATF4 expression (Nagesh et al., 2018), and since ATF4 in turn induces the transcription of L-Pro biosynthesis genes (ALDH18A1 and PYCR1) (Han et al., 2013; D’Aniello et al., 2015; Gonen et al., 2019), it is tempting to hypothesize that a neutralizing response axis (ER stress→ATF4→L-Pro biosynthesis→PRP synthesis/secretion) can be induced by tannins in salivary glands.

Cornified Cell Envelope

Skin is the largest organ of the human body, and it protects internal tissues/organs from water and heat loss, physicochemical insults (e.g., UV light), and microbial attack. Cornifins (or SPRRs) are cross-bridging L-Pro-rich proteins of the cell envelope (Marvin et al., 1992; Steinert et al., 1998a,b), a 5–15 nm thick layer of proteins deposited in epidermis corneocytes (Figure 2). Cornifins are markers of psoriasis syndrome (Luo et al., 2020) and are induced in some tumors (Deng et al., 2020; Sasahira et al., 2021).

Cell Wall Proteins

The extracellular space in plants and algae contains up to 10% dry weight of hydroxyproline (L-Pro-OH)-rich glycoproteins (HRGPs) such as extensins (Showalter, 1993; Lamport et al., 2011), in which L-Pro-OH constitutes up to 30% of total amino acids (Kieliszewski and Lamport, 1994). Besides being structural pilasters, HRGPs are involved in (i) tissue/organ development (embryo, xylem, pod, root hairs, pollen) (Wu et al., 2001; Velasquez et al., 2011; Ogawa-Ohnishi et al., 2013), (ii) a defense mechanism against environmental stress (heat stress, mechanical wounding and bacterial infection) (Francisco and Tierney, 1990; Zhang et al., 2021b), and (iii) an oxygen barrier in the parenchyma of nitrogen-fixing legume root nodules (nodulins) (Scheres et al., 1990; Sherrier et al., 2005). HRGP synthesis requires free L-Pro, and plants respond to pathogen attack by inducing L-Pro accumulation and HRGP synthesis (Fabro et al., 2004).

Proline in Energy Provision

Cells obtain energy/ATP through oxidation of glucose, fatty acids or L-glutamine. However, some cells obtain energy via oxidation of L-Pro in a three-step process (see Figure 3) that converts L-Pro into α-KG, a Krebs cycle intermediate (Tanner et al., 2018). Up to 30 ATP equivalents per L-Pro molecule can sustain the growth of dissimilar cell types, from bacteria to insect muscle cells and human cancer cells (Servet et al., 2012; Nishida et al., 2016). Of note, human genetic defects in L-Pro oxidation are not associated with any developmental deficiency, suggesting that any normal cell type in the human body is strictly reliant on L-Pro energy.

FIGURE 3 Proline is a source of energy and metabolites. Many cell types obtain ATP/energy from mitochondrial oxidation of proline (center), including flight muscle cells of insects (top), protozoan parasites (middle right), and human cancer cells (middle left). Other cells, including motile spermatozoa (bottom left) use the carbon skeleton of proline to produce polyamines via conversion into pyrroline-5-carboxylic acid (P5C) and ornithine. Lastly, retinal epithelial cells (bottom right), produce citrate via conversion of L-proline into L-glutamate (L-Glu) and α-ketoglutarate (α-KG). In the tumor microenvironment, collagens degradation enzymes such as fibroblast activation protein (FAP), and prolyl endopeptidase PREP) release proline-rich peptides and free proline, which after internalization can serves to produce ATP and/or new collagens. Intramitochondrial enzymes involved in L-proline (L-Pro) oxidation, namely proline dehydrogenase (PRODH) and the pyrroline-5-carboxylate dehydrogenase (P5CDH), and glutamate dehydrogenase (GDH), are indicated.

Cancer Cells

Pancreatic and mammary tumor tissues are full of collagens, providing a large reservoir of free L-Pro (Linder et al., 2001; Barcus et al., 2017). Prolyl-specific peptidases are induced in cancer cells and can release L-Pro-rich peptides and free L-Pro in their microenvironment by degrading ECM collagens (Figure 3; Pure and Blomberg, 2018). For instance, free L-Pro is accumulated in esophageal carcinoma tissue, where it reaches significantly higher levels than in neighboring normal tissues (Sun et al., 2019). Free L-Pro is transported inside cancer cells, where it can be used for anabolic and catabolic purposes. Indeed, PDAC cancer cells (Olivares et al., 2017), colorectal cancer cells (Liu et al., 2012a), and transformed mammary epithelial cells (MCF10A H-RasV12) growing as 3D spheroids (Elia et al., 2017) use L-Pro to obtain energy/ATP (Figure 3). L-Pro is also used to produce new collagens (L-Pro recycling), and, eventually, to alter the ECM composition/stiffness (D’Aniello et al., 2020).

Insect Vectors and Protozoan Parasites

Protozoan parasites adapt their metabolism to the mutable environments encountered throughout their life cycle, including the hemolymph of their insect vectors (Bringaud et al., 2012). Trypanosoma brucei, the causative agent of sleeping sickness, is transmitted by tsetse flies (Glossina diptera), and both organisms can oxidize L-Pro to accomplish ATP biosynthesis (Figure 3; Michalkova et al., 2014; Mantilla et al., 2017; Smith et al., 2017; Dolezelova et al., 2020; Haindrich et al., 2021; Villafraz et al., 2021). L-Pro sustains Trypanosoma cruzi (the causative agent of Chagas disease) cell invasion and intracellular epimastigote-to-trypomastigote transition (Figure 3; Martins et al., 2009; Mantilla et al., 2015; Barison et al., 2017). Parasites also utilize L-Pro for anabolic purposes. For instance, halofuginone, a selective inhibitor of PRS, blocks the synthesis of L-Pro-rich proteins and the proliferation of Plasmodium falciparum (the causative agent of malaria) (Hewitt et al., 2017).

Insect Flight Muscle

Flight is one of the highest ATP/energy-requiring processes in animals, and the muscle cells involved can make use of different energy sources including carbohydrates (e.g., honeybee Apis mellifera) and fatty acids (e.g., butterflies) (Bursell, 1975; Candy et al., 1997). Some insects, such as Locusta migratoria, Bombus impatiens (bumblebee), Vespula vulgaris and Glossina diptera, oxidize L-Pro to power flight (Figure 3; Teulier et al., 2016). L-Pro supports flight muscle cells of Aedes aegypti mosquitoes that feed on blood and can obtain free L-Pro from the hydrolysis of blood proteins and/or from alanine in the fat body (Goldstrohm et al., 2003; Scaraffia and Wells, 2003; Mazzalupo et al., 2016). Indeed, free L-Pro is abundant in the hemolymph of adult female mosquitoes and other insects such as Diaphorina citri, the vector of Candidatus Liberibacter asiaticus (huanglongbing) (Killiny et al., 2017).

Polyamine and Citrate Precursors

Some cells use the carbon skeleton of L-Pro to synthesize L-ornithine and L-arginine. For instance, in the gut of neonates, L-glutamate to pyrroline-5-carboxylate conversion is negligible, hence dietary L-Pro is the only source of L-arginine (Tomlinson et al., 2011a,b). In motile human spermatozoa, L-Pro is the precursor of polyamines such as putrescine, spermidine and spermine (Figure 3; Wu et al., 2005, 2008), which are deregulated in hyper-proliferative cancer cells (Bachmann and Geerts, 2018), and thus a potential target for therapeutic anticancer intervention (Murray-Stewart et al., 2016). The three-step L-Pro to α-KG conversion is also activated to generate Krebs-derived metabolic intermediates. For instance, cells of mouse retinal pigment epithelium use L-Pro to synthesize and export citrate, which is consumed by the outer retina (Figure 3; Chao et al., 2017; Yam et al., 2019; Du et al., 2021).

Proline in Antistress Response

Living cells are subjected to a fluctuating environment involving transient or continuous changes in physicochemical parameters such as temperature, humidity and UV radiation. For instance, humans renal and corneal cells are exposed to discontinuous but substantial variations in osmolality/salinity. To prevent the detrimental effects of such harmful environmental imbalances, cells utilize adaptive mechanisms, including accumulation of highly soluble non-toxic osmolytes and chemical chaperones (protein stabilizers) such as L-Pro. Of course, living cells can tolerate extensive accumulation of L-Pro (up to a 100-fold increase) without suffering of the ionic imbalances induced by accumulation of inorganic osmolytes (e.g., Na+, K+, Mg+2 or Ca+2 salts).

Osmoprotection

Hypertonic shocks induce water outflow, which reduces the cell volume and lowers macromolecule stability (Burg et al., 2007; Hoffmann et al., 2009; Stadmiller et al., 2017). Cells respond by accumulating L-Pro, which generates an opposite force of water retention (Figure 4). In bacteria, L-Pro accumulation occurs by uptake of extracellular free L-Pro after the induction (up to 700-fold) of a low-affinity L-Pro transporter (Csonka and Hanson, 1991), through degradation of extracellular L-Pro-rich proteins (Zaprasis et al., 2013) and/or de novo L-Pro biosynthesis (Patel et al., 2018). The ability to accumulate L-Pro is vital to organisms inhabiting mutable (fresh/brackish water, intertidal) habitats, such as gastropod mollusks (Wiesenthal et al., 2019). Plants respond to drought, salinity and freezing temperatures by accumulating L-Pro (Yoshiba et al., 1997; Szabados and Savoure, 2010; Hnilickova et al., 2021; Papu et al., 2021), and in tomato cells concentrations can reach 60 mM (500-fold higher than normal levels) (Handa et al., 1983). L-Pro accumulation protects human cells from hyperosmotic stress (Thiemicke and Neuert, 2021). Indeed, L-Pro uptake facilitates the recovery a viable cell volume after hypertonic stress (Law, 1991; Bevilacqua et al., 2005; Krokowski et al., 2017), and the PP1 phosphatase subunit protein PPP1R15A/GADD34 promotes cis-to-trans Golgi trafficking, and the plasma membrane localization of SLC38A2 L-Pro transporter (Figure 4; Krokowski et al., 2017).

FIGURE 4 Proline in anti-stress response. Proline accumulation is an evolutionary conserved cell defense mechanism against stressful environments; by quenching hydroxyl radicals (⋅OH), protects the cells from ROS oxidations (top left); as osmolyte avoids high salinity-mediated cell shrinkage (top right), as well as the formation of ice crystal, and thus protects many organisms (yeast, plants, overwinter insect) from cell disruption by freezing (middle right). As a chemical chaperone avoids protein denaturation and thus the accumulation of misfolded proteins (middle left), which are potent inducers of a molecular response that involves the protein kinase R-like endoplasmic reticulum kinase (PERK), phosphorylation of eukaryotic initiation factor 2 (EIF2), and eventually, the translation of activating transcription factor 4 (ATF4) (bottom left); ATF4 in turn, induces the expression of solute carrier family 38 member 2 (SLC38A2), growth arrest and DNA damage-inducible protein (GADD34), aldehyde dehydrogenase 18 family member a1 (ALDH18A1) and pyrroline-5-carboxylate reductase 1 (PYCR1) (bottom right). Intracellular proline accumulation through proline uptake and de novo proline biosynthesis (center) can contribute to stress alleviation.

Antifreeze Activity

In yeast, L-Pro accumulation confers ethanol and freezing tolerance (Takagi, 2008). In overwintering insects, L-Pro contributes to water retention and freezing tolerance (Figure 4), and levels increase to ∼80% of the total pool of free amino acids (Kostal et al., 2011, 2016; Rozsypal et al., 2018; Stetina et al., 2018). Of note, hyperprolinemic larvae of the fly Chymomyza costata can survive immersion in liquid nitrogen (−196°C) (Kostal et al., 2011). In Drosophila larvae, an L-Pro-rich diet increases the whole-body L-Pro concentration (up to 60 mM) and freezing tolerance (Kostal et al., 2012).

Radical Scavenging

L-Proline protects various human cells such as HEK293, HeLa, HepG2, Jurkat, BJAB, WM35, skin keratinocytes and fibroblasts against ROS-mediated oxidative stress (Figure 4; Wondrak et al., 2005; Krishnan et al., 2008; Natarajan et al., 2012). Of note, the five-membered ring of L-Pro molecule, known as pyrrolidine or tetrahydropyrrole, quenches hydroxyl radicals (⋅OH) (Signorelli, 2016). In plants L-Pro accumulates in response to oxidative compounds (Yang et al., 2009; Ben Rejeb et al., 2015), and contributes to protect plants from photo-oxidative stress (i.e., light-dependent generation of ROS) (Liang et al., 2013). Recently, it emerged that salivary L-Pro-rich proteins can neutralize ROS, and specifically hydroxyl radicals (Komatsu et al., 2020).

Heavy Metal Detoxification

In plants, L-Pro is accumulated after exposure to heavy metals such as cadmium, chromium, and zinc (Sharma et al., 1998; Verbruggen and Hermans, 2008; Hayat et al., 2012; Dubey et al., 2018; Dong et al., 2021; Pejam et al., 2021; Zdunek-Zastocka et al., 2021), and this mitigates the detrimental effects of cadmium in young olive plants (Zouari et al., 2016) and cultured tobacco cells (Islam et al., 2009). Heavy metal toxicity is usually associated with ROS accumulation (Figure 4). Indeed, cadmium induces p53 (Aimola et al., 2012), a transcriptional inducer of PRODH expression (Polyak et al., 1997), which catalyzes L-Pro oxidation in mitochondria, leading to abnormal ROS production and apoptosis (Liu et al., 2006, 2008, 2009; Oscilowska et al., 2021). Thus, a p53→PRODH→ROS→apoptosis axis may be activated as a response to toxic metals such as cadmium.

ER Stress Relief

At a molecular level, various stressful conditions (e.g., suboptimal temperature, high salinity and oxidative agents) can destabilize the structure and conformation of cellular proteins and other macromolecules. Thus, the accumulation of L-Pro (chemical chaperone) represents a convergent response of cells aimed at inhibiting the formation of unfolded/misfolded protein aggregates. In this context, induction of ATF4 expression (Figure 4), and subsequent enhancement of the transcription of genes involved in L-Pro uptake (SLC38A2) and biosynthesis (ALDH18A2, PYCR1) can contribute to intracellular L-Pro accumulation (D’Aniello et al., 2015). By stabilizing protein folding and/or promoting protein refolding, L-Pro can avoid and/or relieve ER stress.

Proline is a Neural Metabotoxin

Schafer et al. (1962) reported a link between hyperprolinemia (HP), characterized by high levels of plasmatic L-Pro, and neuronal dysfunction in human patients. It later emerged that different forms of hereditary human HP (type I or II) are associated with defects in L-Pro oxidation/degradation (Geraghty et al., 1998; Jacquet et al., 2002). Indeed, ectopic expression of PRODH in glioblastoma cells reduces the level of L-Pro (Cappelletti et al., 2018). Free L-Pro can interfere with excitatory presynaptic transmission, and therefore normal neuronal activity in the central nervous system (CNS) (Shafqat et al., 1995; Velaz-Faircloth et al., 1995; Wyse and Netto, 2011). Of note, the psychostimulant methamphetamine induces L-Pro synthesis in human neuroblastoma cells (Jones et al., 2021).

Schizophrenia Induction and Neurotoxicity

Hyperprolinemia is an etiopathogenetic factor of schizophrenia, a heterogeneous disorder that affects about 21 million people worldwide (Disease et al., 2017). HPI Drosophila models (PRODH mutants) exhibit a depressed ‘sluggish’ behavior (Hayward et al., 1993), while HPII models (defects in P5C to L-glutamate conversion due to a P5CDH mutation) display larval and pupal lethality (He and DiMario, 2011). Conversely, PRODH-overexpressing flies exhibit an opposite ‘aggressive’ behavior (Zwarts et al., 2017). HPI mouse models also exhibit sluggish movements (Blake and Russell, 1972; Kanwar et al., 1975) and schizophrenia-related phenotypes (learning, memory and sensorimotor gating) (Gogos et al., 1999; Paterlini et al., 2005). Human patients with genetic defects in PRODH (HPI, L-Pro levels up to 10-fold higher than normal) or in P5CDH (ALDH4A1; HPII, L-Pro levels up to 15-fold higher and P5C excretion) suffer schizoaffective disorders and schizophrenia (Table 2; Liu et al., 2002; Bender et al., 2005; Raux et al., 2007; Clelland et al., 2011; Nagaoka et al., 2020). At high levels, L-Pro can be oxidized/converted into the neurotransmitter L-glutamate, which is associated with schizophrenia (Figure 5). Excess L-glutamate disturbs synaptic transmission and can destroy neurons, a process known as excitotoxicity (Nadler et al., 1988; Cohen and Nadler, 1997). Moreover, acting as a GABA mimetic inhibitor of the GAD enzyme, L-Pro can reduce the synthesis the GABA neurotransmitter, thereby provoking synaptic dysfunction (Figure 5; Crabtree et al., 2016). Of note, L-Pro antagonizes GABA signaling in plants (Haudecoeur et al., 2009).

FIGURE 5 Proline is a neural metabotoxin. Proline is a metabolic precursor of L-glutamate and gamma-aminobutyric acid (GABA), i.e., the two major neurotransmitters in mammalian brain (top). At high plasma concentrations (2–3 millimolar instead of 150–200 micromolar), as occurs in patient suffering of hyperprolinemia type II (HPII, Table 3), the neurons can channeled free proline into glutamate biosynthesis, thus increasing free glutamate level. At a high level free proline can inhibit glutamate decarboxylase (GAD) enzyme (GABA biosynthesis) thus reducing GABA level in pre synaptic neurons. Altered levels of both these crucial neurotransmitters, and thus alterations in neurotransmission (middle), can explain some of the symptoms of hyperprolinemic patients, including schizophrenia. Defects in neural proline transport, which is mediated by different transporters such as the solute carrier family 6 member 7 (SLC6A7), a high affinity proline transporter, also known as proline transporter 1 (PROT1), and by the solute carrier family 6 member 19 (SLC6A19), also known as system B(0) neutral amino acid transporter 1 (B0AT1), are associated with ataxia and psychosis.

Neural Transporters

In neural tissues, two transporters of L-Pro are expressed; solute carrier family 6 member 7 (SLC6A7, PROT), a member of GABA family, and solute carrier family 6 member 19 (SLC6A19, B°AT1) (Figure 5; Roigaard-Petersen and Sheikh, 1984; Malandro and Kilberg, 1996; Thwaites and Anderson, 2007, 2011; Verrey et al., 2009). Genetic and/or pharmacological inhibition of SLC6A7 reduces locomotor activity and improves mouse learning and memory (Zipp et al., 2014; Schulz et al., 2018). SLC6A7 is induced in fibroblasts of patients suffering of Friedreich’s ataxia, characterized by a lack of control in muscle activity/movements (Napierala et al., 2017). Mutations of SLC6A19 are associated with Hartnup disease, a complex syndrome involving cerebellar ataxia and psychosis (Seow et al., 2004). SLC6A20 (IMINO) is expressed in human neurons and regulates L-Pro and glycine homeostasis (Bae et al., 2021).

Neural Bioactive Peptides

Collagen-derived peptides such as Pro-Pro-OH induce the expression of crucial neural growth factors in the hippocampus of mice, increasing both dopamine concentration in the prefrontal cortex and proliferation of neural progenitor cells, and, eventually, reducing depression-like behavior (Mizushige et al., 2019; Nogimura et al., 2020). L-Pro-containing peptides (Gly-Pro-Glu and cyclo-Gly-Pro) inhibit inflammation and induce vascular remodeling, thereby protecting brain tissues from ischemic injury (Guan and Gluckman, 2009). Moreover, a phosphine analog of Pro-Gly-Pro tripeptide displays neuroprotective properties (Alexey et al., 2021).

Leukodystrophy/Cerebral Hypomyelination

Genetic defects in PYCR2, a PYCR1 paralog, are associated with leukodystrophy-hypomyelinating 10 (HLD10; Table 2), a syndrome characterized by microcephaly and psychomotor disability (Nakayama et al., 2015; Zaki et al., 2016). PYCR2-deficient fibroblasts derived from HLD10 patients are highly susceptible to oxidative stress-induced apoptosis, and this may contribute to this complex phenotype (Reversade et al., 2009; Nakayama et al., 2015).

Proline Modulates Signaling Pathways

The availability of some amino acids influences the activity of cell signaling pathways. For instance, the level of L-glutamine, L-leucine, and L-arginine impacts the mechanistic target of rapamycin (mTOR) pathway (Curi et al., 2007; Xie and Klionsky, 2007; Ryter et al., 2013; Bar-Peled and Sabatini, 2014; Lahiri et al., 2019). L-tyrosine and L-phenylalanine modulate the G protein-coupled receptor 142 (GPR142)-mediated pathway (Lin et al., 2016). It emerged that mESCs, isolated from mouse blastocysts, suffer from a finely regulated partial shortage of L-Pro, and that an increase in free L-Pro availability modulates the activity of the amino acid stress response (AAR), fibroblast growth factor/extracellular signal-related kinase (FGF/ERK), TGFβ, wingless and int-1 (WNT), and redox signaling pathways. As expected, specific signaling modulators such as halofuginone (AAR inducer), SB431542 (TGFβ inhibitor), CHIR99021 (WNT agonist) and PD0325901 (MEK/ERK inhibitor) fully counteract L-Pro supplementation effects (Comes et al., 2013; D’Aniello et al., 2015). Moreover, L-Pro impacts mTOR pathway in porcine trophectoderm cells (Liu et al., 2021).

Amino Acid Starvation Response

In cultured ESCs, exogenously available L-Pro, at a physiological concentration range (50–250 μM), disables the AAR pathway by improving L-Pro-tRNA loading, inactivating (dephosphorylation) eukaryotic translation initiation factor alpha (EIF2α), and eventually, preventing translation of ATF4 mRNA (Figure 6; D’Aniello et al., 2015). In the absence of ATF4, the genes involved in L-Pro biosynthesis (ALDH18A1 and PYCR1), and L-Pro uptake (SLC38A2 and GADD34) are silenced (Gaccioli et al., 2006; D’Aniello et al., 2015). L-Pro-ATF4 interplay also impacts cardiac fibroblast metabolism (Qin et al., 2017). Human kidney and breast cancer cells suffer from a similar intrinsic and partial shortage of L-Pro (Loayza-Puch et al., 2016; Sahu et al., 2016).

FIGURE 6 Proline modulates signaling pathways. Supplemental proline, after being transported into the cell cytoplasm can be used and/or for mitochondrial oxidation (catabolism) and/or for the loading of uncharged tRNA (anabolism). ROS are byproducts of proline oxidation (top left) and their accumulation can stabilize the hypoxia inducible factors (HIF), and modulate redox signaling (middle left). Proline-tRNA loading induces dephosphorylation (inactivation) of the general control non-repressible 2 (GCN2) kinase, also known as eukaryotic translation initiation factor 2 alpha kinase 4 (EIF2AK4). The inactive form of GCN2 is unable to phosphorylate eukaryotic translation initiation Factor 2A (EIF2A), and to promote translation of activating transcription factor 4 (ATF4), so inactivating the amino acid stress response (AAR). Proline-tRNA loading also improves collagens expression, which are modulators of the integrin linked kinase/extracellular signal-regulated Kinase (ILK/ERK) super-pathway (middle right). Proline abundance induces left-right determination factors (LEFTY1, LEFTY2), the phosphorylation of mothers against decapentaplegic homolog 2 (SMAD2), and thus, the activation of the transforming growth factor beta signaling pathway (bottom right). Proline abundance also induces the expression of the protein kinase domain containing, cytoplasmic (PKDCC), and the delocalization the E-cadherin from plasma membrane to trans Golgi (bottom left).

Extracellular Signal-Regulated Kinase

In stem and cancer cells, a high L-Pro regimen induces phosphorylation of ERK1 and enhances the transcription of ERK-related genes (Figure 6; Liu et al., 2006; D’Aniello et al., 2016). Supplemental L-Pro induces the expression of growth factors (FGF5, FGF8, and FGF13) and the synthesis of collagen, and this can contribute to the induction of the ILK/ERK super-pathway, as revealed by transcriptome analysis (Comes et al., 2013; D’Aniello et al., 2016, 2019b). Indeed, collagen mimics consisting of repeated units (5 or 10) of the Pro-Pro-Gly tripeptide activate phosphoinositide 3-kinase (PI3K)-dependent p38 mitogen-activated protein kinase (MAPK) phosphorylation (Weinberger et al., 2005).

Transforming Growth Factor

In ESCs, supplemental L-Pro induces expression of left-right determination factors (LEFTY1 and LEFTY2) and phosphorylation (activation) of small mother against decapentaplegic (SMAD2), which are extracellular inhibitors and intracellular effector of TGFβ-signaling, respectively (Figure 6; D’Aniello et al., 2015, 2016). In VSMCs of injured arteries (Majesky et al., 1991; Ensenat et al., 2001), and in meniscal fibrochondrocytes (Pangborn and Athanasiou, 2005), supplemental TGFβ induces L-Pro uptake and collagen deposition. A L-Pro→TGFβ→L-Pro regulatory loop should allow the induction of collagen synthesis only when free L-Pro is sufficient to warrant timely tRNA loading, thus avoiding ribosome stalling (ER stress).

Wingless and Int-1

Pluripotent stem cells tend to proliferate as tightly packed cell aggregates, a trend that is inverted by a high L-Pro regimen (Comes et al., 2013). This phenotypic effect of L-Pro is fully counteracted by CHIR99021, a WNT signaling agonist. Moreover, L-Pro abundance delocalizes E-cadherin from the plasma membrane, where it is involved in cell-cell adherent junctions, to the Golgi. This subcellular redistribution of E-cadherin relies on the protein kinase domain containing, cytoplasmic (PKDCC), also known as vertebrate lonesome kinase (VLK) (Figure 6; Comes et al., 2013). L-Pro supplementation induces the expression of insulin-related genes such as IGF2, IGFR1, IGFBP3, IRS1 and IRS2 (D’Aniello et al., 2016), which are modulators of glycogen synthase kinase 3 (GSK3) activity (Desbois-Mouthon et al., 2001), and enhanced translation of collagen XVIII, which contains a frizzled-like domain (Heljasvaara et al., 2017), and can contribute to WNT modulation.

Autophagy

In mouse ESCs, L-Pro supplementation enhances L-Pro-tRNA loading and inhibits autophagy. Accordingly, halofuginone inhibits L-Pro-tRNA loading and activates autophagy (D’Aniello et al., 2015). In human and murine ECSLC, knockdown of Tap73 tumor protein reduces L-Pro biosynthesis and induces autophagy (Sharif et al., 2019). Protracted exposure to free L-Pro induces stem cell motility, invasiveness, and macro-autophagy (D’Aniello et al., 2015). In cancer cells overexpressing PRODH and exposed to a high exogenous L-Pro regimen, autophagy is induced (Liu et al., 2012b).

Reactive Oxygen Species and Hypoxia-Inducible Factors

Electrons released during mitochondrial L-Pro oxidation reduce flavin adenine dinucleotide (FAD) to generate FADH2 and/or O2 during the production of ROS (Figure 6; Donald et al., 2001). In Arabidopsis thaliana, PRODH-mediated production of sub-lethal levels of ROS induces disease resistance (Cecchini et al., 2011), and in Caenorhabditis elegans this prolongs the nematodes life span (Zarse et al., 2012). In C. elegans, defects in L-Pro catabolism results in premature reproductive senescence and male infertility (Yen and Curran, 2021). In cancer cells, the L-Pro->PRODH->ROS axis can activate either pro-tumorigenic (cell survival) or anti-tumorigenic (cell death) signaling (Moloney and Cotter, 2018; Oscilowska et al., 2021). In rats’ blood cells, hyperprolinemia increases oxidative damage of proteins, lipids and DNA (Ferreira et al., 2014). The effect of L-Pro on intracellular redox balance can be amplified by an NADPH-consuming futile cycle of L-Pro/P5C inter-conversion (Phang, 2019). Besides ROS, oxidative deamination of L-Pro generates α-KG, an essential substrate for hydroxylating dioxygenase enzymes, including PHD1-3 enzymes that catalyze the post-translational hydroxylation of specific proline residues of hypoxia-inducible factors (HIFs) resulting in destabilization of the protein. Indeed, the induction of PRODH activity in cancer cells destabilizes HIF1α and down-regulates the transcription of HIF1α target genes (Liu et al., 2009).

Proline is an Epigenetic Modifier

Several metabolites may influence, directly or indirectly, the activity of chromatin-modifying enzymes, and thus the epigenetic landscape of the cells (Reid et al., 2017; D’Aniello et al., 2019b; Surguchov et al., 2021). L-Pro is not a substrate, product, cofactor, or allosteric regulator of any epigenetic enzyme, but in ESCs its availability influences the activity of ten-eleven translocation (TET; DNA) and Jumonji (JMJ, histone) demethylase enzymes, which are strictly dependent on the availability of O2, α-KG, and ascorbic acid (vitamin C, VitC) to be active (Figure 7; Comes et al., 2013; D’Aniello et al., 2016, 2019b).

FIGURE 7 Proline is an epigenetic modifier. At a high proline regimen, extracellular proline is channeled into the cell cytoplasm through a transport system, as the solute carrier family 38 member 2 (SLC38A2), also known as system N amino acid transporter 2 (SNAT2), and used to charge tRNA molecules (top right), in a reaction catalyzed by the prolyl-tRNA synthetase (PRS). A high level of charged Proline-tRNA is an essential requisite for collagens synthesis (middle). A high fraction of L-Pro residues of the nascent molecules of collagens are hydroxylated by prolyl 4-hydroxylases (P4H 1, 2, 3) dioxygenases enzymes, a process that consume huge amounts of ascorbic acid (vitamin C, VitC) and α-ketoglutarate (α-KG) (middle right). VitC is transported by members of the solute carrier family 23 (SLC23A1, 2; bottom), whereas α-KG is produced inside mitochondria using proline and/or glutamate as precursors (top left). A sudden and sizeable increment of P4H activity in the endoplasmic reticulum (ER) can reduce the availability of VitC and α-KG for the activity of nuclear dioxygenases involved in DNA methylcytosine hydroxylation/demethylation (ten-eleven translocation, TET 1, 2, 3) and in histones lysine hydroxylation/demethylation (jumonji, JMJ) (bottom left). This compartmentalized metabolic perturbation, by increasing the DNA and histones methylation levels, can modify the epigenetic landscape of the cells.

DNA Methylation

L-Proline supplementation increases DNA 5-methylcytosine (5mC) and reduces 5-hydroxy-methylcytosine (5hmC) levels, inducing ∼1 × 103 DMRs distributed throughout all chromosomes of ESCs, with ∼50% of DMRs located in gene promoter regions (mostly H) and ∼20% in gene enhancers (D’Aniello et al., 2016). Importantly, ∼95% of genome sites hypermethylated after L-Pro supplementation are hypomethylated following VitC (50–150 μM) supplementation, indicating that L-Pro and VitC induce opposite epigenetic alterations in the same DNA regions. VitC is needed for the activity of TET demethylases (Blaschke et al., 2013), and ∼90% of genomic regions hypermethylated in by a high L-Pro regimen are hypermethylated also in cells lacking TET-mediated DNA demethylase activity (Lu et al., 2014; D’Aniello et al., 2019a).

Histone Methylation

L-Proline supplementation also triggers a genome-wide reprogramming of H3K9 methylation status, altering more than 1.6 × 104 genome sites located mainly in non-coding intergenic regions (Comes et al., 2013). Demethylation is catalyzed by members of the JMJ dioxygenase enzyme family, and upon silencing of Jmjd1a (H3K9 demethylase), ESCs adopt a molecular (upregulation of Fgf5 and Brachyury genes) and phenotypic (irregular flat-shaped colonies, sensitivity to trypsin digestion) state of pluripotency, similar to that induced by a high L-Pro regimen (Loh et al., 2007). Differences in the expression level and/or in the kinetic parameters (substrate affinity) of different JMJs can explain how L-Pro abundance alters the methylation level of some specific lysine residues (K9, K36) of histone H3.

Metabolic Imbalance

It recently emerged that a sudden and substantial increase in L-Pro stimulates collagen synthesis in the ER of ESCs (D’Aniello et al., 2019a), and that a significant fraction of L-Pro residues of nascent collagens are hydroxylated by prolyl 4-hydroxylase (P4H) dioxygenases, in particular by P4HA1 and P4HA2 enzymes, with depletion of α-KG and VitC. Under such conditions, nuclear dioxygenases such as TETs and JMJs lose activity, and consequently, DNA and histone methylation levels increase (Figure 7). Genetic and pharmacological evidence supports the idea that an abrupt induction of collagen synthesis leads to a similar metabolic imbalance and epigenome alterations also in cancer cells (D’Aniello et al., 2019a).

Proline Induces Proliferation of Stem and Tumor Cells

Pluripotent stem cells shape the ICM in blastocysts of mammals and the apical meristems of plant organs (shoots and roots), and can self-renew and undergo differentiation into various somatic lineages. Cancer cells often display a stem cell-like growth behavior. Of note, L-Pro is a growth limiting metabolite (intrinsic starvation) for embryonic stem cells (D’Aniello et al., 2015), and for many different human cancer cells (D’Aniello et al., 2020). Similarly, L-Pro metabolism also influences the proliferation of meristematic and plant tumor cells (Trovato et al., 2001; Biancucci et al., 2015).

Stem Cells

Supplemental L-Pro (50–250 μM) improves proliferation of ESCs (Figure 8; Washington et al., 2010; Casalino et al., 2011), development of pre-implantation embryos (Morris et al., 2020) and fetus survival (Liu et al., 2019). L-Pro is internalized into stem cell cytoplasm through the SLC38A2 (SNAT2) transporter (Tan et al., 2011), and halofuginone (prolyl-tRNA synthetase inhibitor) fully counteracts L-Pro induction of cell proliferation (D’Aniello et al., 2015). Moreover, halofuginone and L-Pro modify the ESC transcriptome in opposite directions (D’Aniello et al., 2015), showing that mouse ESCs are partially starved of L-Pro, even after incubation in complete rich medium. Of note, during in vitro fertilization of mouse oocytes, L-Pro supplementation improves stem cells (ICM) proliferation and embryo development (Treleaven et al., 2021).

FIGURE 8 Proline induces proliferation of stem and cancer cells. Proline availability controls proliferation of pluripotent embryonic stem cells (ESCs), isolated from the inner cell mass of 3.5 days post coitum (dpc) mouse blastocysts (top left). Proline induces proliferation also of plant stem cells that shaped the shoot and root apical meristems and are responsible of post-embryonic organogenesis (top right). Proline improves proliferation and invasiveness of cancer cells primarily by increasing protein synthesis (bottom left). Deregulation of proline metabolism is involved in development and growth of plant tumors, such as the neoplastic hairy roots and are tumor-like structures known as crown galls. Usually, these tumors are formed in the roots or in the lower stem region (bottom right), and display a single and/or several centers of deregulated cell proliferation (hyperplasia), surrounded by hypertrophic tissues (bottom right).

Cancer Cells

L-Proline shortage is a major cause of partial ribosome stalling (diricore analysis) suffered by kidney and breast cancer cells (Loayza-Puch et al., 2016). Likewise, up-regulation of L-Pro biosynthesis genes (ALDH18A1 and PYCR1) also reveals L-Pro starvation in tumor cells (D’Aniello et al., 2020). Moreover, ALDH18A1 knock-down activates AAR stress signaling, and reduces melanoma tumor growth both in vitro and in vivo (Kardos et al., 2015), whereas PYCR1 induction improves proliferation and invasiveness of breast, esophagus, lung, melanoma, pancreas, and prostate cancer cells (Nilsson et al., 2014; Ding et al., 2017; Zeng et al., 2017; Cai et al., 2018; Ye et al., 2018; Kardos et al., 2020; Forlani et al., 2021). Of note, kindlerin 2 (KINDLING-2) protein stabilizes the mitochondrial PYCR1 enzyme, increasing L-Pro synthesis and lung adenocarcinoma cell proliferation (Guo et al., 2019). Importantly, translocation of KINDLING-2 into mitochondria is regulated by ECM stiffness (Guo et al., 2019) and PINCH-1 (particularly interesting new Cys-His protein 1) protein (Guo et al., 2020; Ding et al., 2021), and PYCR1 activity is modulated by the mitochondrial deacetylase sirtuin (SIRT3) (Chen et al., 2019). PYCR1 stabilization by KINDLING-2 induces L-Pro synthesis in human lung fibroblasts and contributes to pulmonary fibrosis progression (Zhang et al., 2021a).

Meristematic Cells

Post-embryonic organogenesis in adult plants relies on apical meristems, and a fine-tuned balance between self-renewal and differentiation fates adapts organ morphogenesis to a fluctuating environment (Figure 8; Mattioli et al., 2009; Lehmann et al., 2010; Szabados and Savoure, 2010). In Arabidopsis, L-Pro availability controls root meristem activity (Biancucci et al., 2015) by modifying the expression of L-Pro-rich proteins, and regulating a compartmentalized (mitochondria/cytoplasm) cycle of L-Pro synthesis and degradation that modifies the NADP+/NADPH ratio (Verslues and Sharma, 2010). Therefore, it is tempting to hypothesize that the induction of L-Pro accumulation during osmotic shock (see Figure 4), by altering the behavior/fate of stem cells, can contribute to couple a harmful environment (soil wetness) with the induction of organogenesis (root elongation).

Neoplastic Hairy Roots

L-Proline metabolism and plant tumor development are linked by the rolD gene of Agrobacterium rhizogenes, which encodes OCD that catalyzes L-Orn to L-Pro conversion, and is essential for the induction of neoplastic hairy roots (Figure 8; White et al., 1985; Costantino et al., 1994; Trovato et al., 2001). L-Pro accumulates in root tumor-like galls induced by the nematode Meloidogyne javanica or by Agrobacterium tumefaciens (Wachter et al., 2003; Trovato et al., 2018). Importantly, bacteria-induced tumorigenesis is attenuated in transgenic plants with low L-Pro levels (Haudecoeur et al., 2009).

Proline Controls Cell Plasticity

Some metabolites modulate relevant phenotypic transformations such as stem cell differentiation, somatic cell reprogramming, and EMT. For instance, butyric acid drives the differentiation of MSCs into adipocytes (Tugnoli et al., 2019), and, conversely, enhances the reprogramming efficiency of fetal fibroblasts into pluripotent cells (Liang et al., 2010; Mali et al., 2010). Likewise, VitC improves cell differentiation (Cao et al., 2012) and reprogramming (Esteban et al., 2010). Similarly, L-Pro governs the morphology, migratory behavior and pluripotency state of stem cells (Washington et al., 2010; Casalino et al., 2011).

Cytoskeletal Rearrangements

Embryonic stem cells seeded at a low density (50–250 cells/cm2) in a high L-Pro regimen develop flat-shaped cell colonies formed by a core of adherent cells surrounded by a crown of detached cells showing mesenchymal features such as long actin stress fibers and mature focal adhesion complexes (Figure 9; Casalino et al., 2011; Comes et al., 2013). These L-Pro-induced cells are in a ‘metastable’ equilibrium, spread out from the colony core and rapidly moving back to re-establish adherent cell-cell contacts, a fully reversible phenotypic transition known as embryonic stem cell-to-mesenchymal transition (esMT) (Comes et al., 2013). Of note, in detached cells, E-cadherin is delocalized from the plasma membrane to the Golgi (see Figure 6) and unlike canonical EMT, during esMT the CDH1 gene is not down-regulated (Comes et al., 2013).

FIGURE 9 Proline controls cell plasticity. After proline supplementation (50–150 μM) cultured embryonic stem cells undergo a fully reversible phenotypic transition named embryonic stem-to-mesenchymal transition (esMT); after 3–4 days of incubation the cells become motile, spread out from the cell colony core (top left), and display complex cytoskeleton rearrangements, with prominent actin stress fibers and focal adhesions (top right). The E-cadherin protein, which is an essential component of cell-cell adherens junctions, is delocalized from the plasma membrane to the Golgi complex (middle left). Even after acquiring mesenchymal features, the stem cells retain a high degree of pluripotency: (i) colonize mouse embryos after being injected in the inner cell mass of developing mouse blastocysts (middle); (ii) undergo in vitro neuronal differentiation (middle) and; (iii) after being injected in the tail vein of mouse (bottom left), the cells reach the lungs, and after extravasation, generate metastatic teratomas, which display histologically noticeable differences from normal lung tissue (bottom right).

Invasion/Metastasis

After exposure to a high L-Pro regimen, ESCs acquire the ability to migrate through matrigel-coated porous membranes in response to serum gradients, or toward chemo-attractants such as EGF and stromal cell-derived factor 1 (Comes et al., 2013). These cells are able to reach the lung tissues after intravenous injection, and to generate tumors with a histological complexity of teratomas (Comes et al., 2013). Thus, a high L-Pro regimen converts adherent stem cells into spindle-shaped, motile and metastatic stem cells (Figure 9).

Metabolic Reprogramming

The morphological changes induced by L-Pro supplementation are associated with a metabolic switch from a bivalent to a more glycolytic metabolism. Indeed, metabolome profile analysis revealed higher lactate levels and increased susceptibility to 2-DG, a specific inhibitor of the glycolytic pathway (D’Aniello et al., 2016). Moreover, a high L-Pro regimen reduces the mitochondrial membrane potential, which relies on oxidative phosphorylation rates (D’Aniello et al., 2017), thus supporting glycolytic energy metabolism.

Pluripotency

L-Proline supplementation remodels the transcriptome of naïve ESCs by altering the expression of ∼1.5 × 103 protein-coding genes mainly related to cell adhesion, cell junction, and cell motility functions (Comes et al., 2013; D’Aniello et al., 2017). Cells treated with L-Pro are leukemia inhibitory factor (LIF)-dependent, express pluripotency markers as Nanog homeobox, can differentiate into cardiomyocytes and neurons in vitro, and are able to colonize mouse blastocysts (chimeric embryos; Figure 9; Casalino et al., 2011). Recently, Cermola et al. (2021) reported that L-Pro-treated ESCs can differentiate into primordial germ cell like cells (PGCLCs), and are competent to develop elongated gastruloids, suggesting that L-Pro abundance drives ESCs into an early primed state of pluripotency.

Proline Antagonists

L-Proline-induced esMT is inhibited by well-known chemical modulators of key signaling pathways such as CHIR99021 (WNT agonist) and PD0325901 (TGFβ antagonist) (D’Aniello et al., 2016). Moreover, D’Aniello et al. (2019a) made use of the cell colony morphology to develop a high-throughput screening method, and identified 14 FDA-approved drugs (from 1200 assayed) able to inhibit esMT without preventing L-Pro-induced cell proliferation. Spiramycin (macrolide), Propafenone (flavonoid) and Budesonide (steroid) inhibit esMT and have very different chemical structures, implying molecular complexity in L-Pro-mediated control of stem cell plasticity. Importantly, VitC, but not other antioxidants such as NAC, is a full inhibitor of esMT (D’Aniello et al., 2016).

Conclusion and Perspectives

The control of L-Pro metabolism in human cells is relatively poorly understood, even though it might have a great impact on human health (Figure 10). For instance, PrAMPs displaying potent antimicrobial activity and low toxicity for human cells could be efficient tools to fight multidrug-resistant pathogens, a serious public health concern (Charon et al., 2019). Salivary proline-rich peptides able to neutralize microbe attacks could contribute to avoiding the development of dental caries, an infectious disease that affects billions of people (Werneck et al., 2010; Stromberg et al., 2017). Moreover, salivary proteins could contribute to food choices, and so to nutrition status and health (Melis et al., 2021). Translational suppression of proline-rich proteins by pharmacological targeting of the PRS is emerging as an attractive therapeutic approach for the treatment of different diseases. Of note, halofuginone, a specific inhibitor of the PRS, is already in clinical trials for the treatment of fibrotic diseases (Pines and Spector, 2015), and has been recently shown to inhibit SARS-CoV-2 infection, suppressing the translation of proline-rich host attachment factors (Sandoval et al., 2021).

FIGURE 10 This illustration encompasses the multifaceted roles of proline in cell biology, including: building block of proteins (collagens, cornifins, salivary proteins); energy fuel (bacteria, parasites, cancer cells); stress defender (cold shock, drought/salinity, ER stress); proliferation inducer (stem, meristematic, cancer cells); plasticity controller (cell shape, motility); epigenetic modifier (DNA/histone methylation); modulator of cell signaling pathways (AAR, autophagy, ERK, TGFβ) and neural toxin associated (schizophrenia).

Exploitation of L-Pro as a source of carbon and/or energy appears to be an adaptive response of cells to high-L-Pro microenvironments, which can be generated by pathological tissue damage (bacterial invasion, cancer progression, trauma). Although never measured, it is possible to speculate that in an extremely confined extracellular space, free L-Pro can reach exceptionally high concentrations. L-Pro supports invasiveness of bacteria, parasites and cancer cells, all processes that engage tissue degradation/remodeling (Christgen and Becker, 2019; D’Aniello et al., 2020), and D-Pro-derived peptidomimetic inhibitors of human gelatinases/metalloproteinases involved in tissue remodeling are potential anti-metastatic agents (Lenci et al., 2021). Moreover, enzymes involved in L-Pro metabolism are potential targets of antiparasitic drugs (Saye et al., 2017; Ugwu et al., 2018).

Various stressful conditions, including suboptimal temperature, high salinity and oxidative agents, can alter the conformations of proteins and other macromolecules. Since L-Pro is a potent and non-toxic chemical chaperone, its intracellular accumulation could be an evolutionarily conserved response aimed at inhibiting the formation of unfolded/misfolded protein aggregates. Indeed, hemocompatible gold nanoparticles coated with L-Pro inhibit both collagen fibril formation (Anand et al., 2017) and insulin aggregation (Prajapati et al., 2021), and could provide a basis for creating antifibrotic and antiamyloid formulations.

Numerous studies conclude that at high levels, free L-Pro is a neurotoxin. Lactic acid inhibits PRODH activity, and lactic acidosis syndrome (blood lactic acid >5 mM) is frequently associated with hyperprolinemia, supporting the idea that in adult humans L-Pro homeostasis is strictly dependent on L-Pro oxidation. Of note, L-Pro at high levels is harmful for brain/neural activity, but acting as a chemical chaperone it can prevent protein unfolding/misfolding (Liang et al., 2014). Thus, regulation of L-Pro metabolism is studied in the context of neurodegenerative diseases associated with the formation of protein aggregates, as exemplified by Huntington’s, Parkinson’s, and Alzheimer’s (Powers et al., 2009; Khan et al., 2010).

Beyond some cancer cells, whether and which normal human cells oxidize L-Pro, and whether this contributes to maintain prolinemia, remains unknown. The concomitant activation of L-Pro oxidation (for ATP production in mitochondria) and tRNA loading (for collagen synthesis in the ER) remains uncharacterized at the single-cell level. By generating sublethal amounts of ROS, L-Pro oxidation can induce redox signaling, and eventually a compensatory stress response, through the induction of ROS consuming/neutralizing enzymes. Importantly, in bacteria (Zhang et al., 2015), fungi (Chen and Dickman, 2005) and nematodes (Zarse et al., 2012), L-Pro oxidation increases cell resilience to stressful conditions. However, the induction of stress tolerance by L-Pro oxidation in human cells remains an open question.

Aging is usually associated with a significant reduction (quantitative and qualitative) in CTs (tendon, bone, cartilage), for which L-Pro is essential. Of note, older people and patients suffering hereditary defects L-Pro biosynthesis share a similar aged appearance (e.g., osteopenia, cataracts, wrinkled skin, cutis laxa). Furthermore, sedentary life-induced sarcopenia is associated with hyperprolinemia, but its impact on neural disorders suffered by the elderly is unknown.

How L-Pro availability modulates stem and cancer cell proliferation is an interesting question that is getting increasingly attention. Free L-Pro can improve the translation of L-Pro-rich proteins (Sabi and Tuller, 2015; Chyzynska et al., 2021) or simple protein stretches, as demonstrated for HOXB4 involved in leukemia (Cusan et al., 2017). Recently, cell-based drug screening identified 137 drugs (out of 1200 assayed) able to inhibit stem cell proliferation, of which 80% also inhibited cancer cells (D’Aniello et al., 2019a), suggesting a similar chemosensitivity spectrum. Thus, the development of therapeutic strategies to target L-Pro metabolism may provide new options to eradicate cancer cells. Importantly, L-Pro abundance induces invasiveness in stem cells, a peculiar trait of migrating cancer cells. Certainly, the ability of L-Pro to control morphogenesis is not limited to stem cells. For instance, L-Pro availability influences plant shoot and root development (see Biancucci et al., 2015, for a review), hyphal morphology in the pathogenic fungus Colletotrichum trifolii (Memmott et al., 2002), and filamentation (yeast-to-hyphal transition) in the pathogenic yeast Candida albicans (Dabrowa et al., 1976; Silao et al., 2019).

Author Contributions

EP and GM contributed to the conception and design of the review. FC, CD’A, AF, OG, and DD performed the literature search, and wrote the first draft of the manuscript. EP and FC prepared the figures. EP and GM critically revised the text and provided substantial scientific contribution. All authors approved the final version of the manuscript.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

We are most grateful to Prof. Maurizio Iaccarino for critical comments.

Abbreviations

AAR amino acid starvation response

Acetyl-CoA acetyl coenzyme A

ADCL3 autosomal dominant cutis laxa 3

α-KG α-ketoglutarate

ALDH18A1 P5C synthase

AMPs antimicrobial peptides

ARCLII autosomal recessive cutis laxa type IIB

VitC, ascorbic acid vitamin C

ATF4 activating transcription factor 4

BDNF brain-derived neurotrophic factor

BJAB human lymphoma cell line

CTs connective tissues

C/EBP CCAAT/enhancer-binding protein

ChIP-Seq chromatin immunoprecipitation sequencing

CYR61 cysteine-rich angiogenic inducer 61

DIRICORE differential ribosome codon reading

DMR differentially methylated regions

2-DG 2-deoxy-D-glucose

ECM extracellular matrix

ECSLC embryonal carcinoma stem-like cells

EGF epidermal growth factor

EIF2A eukaryotic translation initiation factor 2

EIF5A eukaryotic translation initiation factor 5A

EMT epithelial-to-mesenchymal transition

ER endoplasmic reticulum

ERK extracellular signal-regulated kinase

FAP fibroblast activation protein

FGF5 fibroblast growth factor 5

FGF8 fibroblast growth factor 8

FGF13 fibroblast growth factor 13

FBS fetal bovine serum

GABA γ-aminobutyric acid

GAD L-glutamate decarboxylase

GCN2 general control non-derepressible 2

GDH L-glutamate dehydrogenase

GPR142 G-protein -coupled receptor protein 142

HEK293 human embryonic kidney cell line

HeLa human cervical cancer cell line

HEPG2 human liver cancer cell line

HIF-1 α hypoxia inducible factor alpha-subunit

HPI and HPII hyperprolinemia type I and II

IGF-1 insulin-like growth factor 1

ICM inner cell mass

JMJ jumonji dioxygenases

Jurkat human T lymphocyte cell line

mESCs mouse embryonic stem cells

mTOR mammalian target of rapamycin

5mC 5-methyl cytosine

5hmC 5-hydroxymethyl cytosine

MSCs mesenchymal stem cells

NEAA non-essential amino acid

NGF nerve growth factor

NMDA N-methyl -D-aspartate

NMR nuclear magnetic resonance

OCD ornithine cyclodeaminase

PDAC pancreatic ductal adenocarcinoma

PKDCC protein kinase domain containing

PHD1-3 HIF prolyl hydroxylases 1-3

P4HA prolyl-hydroxylase

P5C Δ 1-pyrroline-5-carboxylate

P5CDH P5C dehydrogenase

p53 tumor suppressor protein 53

L-Pro L-proline

PRODH L-proline dehydrogenase

L-Pro-OH trans-4-hydroxy-L-proline

PRS prolyl-tRNA synthetase

PYCR P5C reductase

PREP prolyl endopeptidase

ROS reactive oxygen species

SAM S-adenosyl -methionine

SDF-1 stromal cell-derived factor-1

SLC38A2 solute carrier family 38 member 2

SPRR small proline-rich region protein

TCA tricarboxylic acid

TET ten-eleven translocation dioxygenase

TGF β transforming growth factor beta

UV ultraviolet

VSMCs vascular smooth muscle cells

WNT wingless and/NT-1.

Funding. This work was supported by AIRC (IG 20736), POR Campania FESR 2014/2020 (Project SATIN), European Training Network RENOIR (https://renoir-itn.eu/), and Italian Ministry of Education-University-Research (CTN01_00177 Cluster ALISEI_IRMI and PRIN 2017XJ38A4).
==== Refs
References

Agami C. P. N. Puchot C. Sevestre H. (1987). The role of proline in the asymmetric step of the woodward synthesis of erythromycin. Tetrahedron 43 :8 .
Agerberth B. Lee J. Y. Bergman T. Carlquist M. Boman H. G. Mutt V. (1991). Amino acid sequence of PR-39. Isolation from pig intestine of a new member of the family of proline-arginine-rich antibacterial peptides. Eur. J. Biochem. 202 849–854. 10.1111/j.1432-1033.1991.tb16442.x 1765098
Aimola P. Carmignani M. Volpe A. R. Di Benedetto A. Claudio L. Waalkes M. P. (2012). Cadmium induces p53-dependent apoptosis in human prostate epithelial cells. PLoS One 7 :e33647 . 10.1371/journal.pone.0033647 22448262
Alderson T. R. Lee J. H. Charlier C. Ying J. Bax A. (2018). Propensity for cis-Proline formation in unfolded proteins. Chembiochem 19 37–42. 10.1002/cbic.201700548 29064600
Alexey V. V. Maxim D. E. Lyudmila A. A. Alexey U. A. Valery S. P. Kristina S. N. (2021). Phosphine modification of proline-glycine-proline tripeptide and study of its neuroprotective properties. Biochem. Biophys. Res. Commun. 539 15–19. 10.1016/j.bbrc.2020.12.087 33412416
Anand B. G. Dubey K. Shekhawat D. S. Prajapati K. P. Kar K. (2017). Strategically designed antifibrotic gold nanoparticles to prevent collagen fibril formation. Langmuir 33 13252–13261. 10.1021/acs.langmuir.7b01504 29072918
Bachmann A. S. Geerts D. (2018). Polyamine synthesis as a target of MYC oncogenes. J. Biol. Chem. 293 18757–18769. 10.1074/jbc.tm118.003336 30404920
Bae M. Roh J. D. Kim Y. Kim S. S. Han H. M. Yang E. (2021). SLC6A20 transporter: a novel regulator of brain glycine homeostasis and NMDAR function. EMBO Mol. Med. 13 :e12632 .
Baliga C. Brown T. J. Florin T. Colon S. Shah V. Skowron K. J. (2021). Charting the sequence-activity landscape of peptide inhibitors of translation termination. Proc. Natl. Acad. Sci. U S A. 118 :e2026465118 . 10.1073/pnas.2026465118 33674389
Barcus C. E. O’leary K. A. Brockman J. L. Rugowski D. E. Liu Y. Garcia N. (2017). Elevated collagen-I augments tumor progressive signals, intravasation and metastasis of prolactin-induced estrogen receptor alpha positive mammary tumor cells. Breast Cancer Res. 19 :9 .
Barison M. J. Rapado L. N. Merino E. F. Furusho Pral E. M. Mantilla B. S. Marchese L. (2017). Metabolomic profiling reveals a finely tuned, starvation-induced metabolic switch in Trypanosoma cruzi epimastigotes. J. Biol. Chem. 292 8964–8977. 10.1074/jbc.m117.778522 28356355
Bar-Peled L. Sabatini D. M. (2014). Regulation of mTORC1 by amino acids. Trends Cell Biol. 24 400–406.24698685
Baumgartner M. R. Hu C. A. Almashanu S. Steel G. Obie C. Aral B. (2000). Hyperammonemia with reduced ornithine, citrulline, arginine and proline: a new inborn error caused by a mutation in the gene encoding delta(1)-pyrroline-5-carboxylate synthase. Hum. Mol. Genet. 9 2853–2858. 10.1093/hmg/9.19.2853 11092761
Ben Rejeb K. Lefebvre-De Vos D. Le Disquet I. Leprince A. S. Bordenave M. Maldiney R. (2015). Hydrogen peroxide produced by NADPH oxidases increases proline accumulation during salt or mannitol stress in Arabidopsis thaliana. New Phytol. 208 1138–1148. 10.1111/nph.13550 26180024
Bender H. U. Almashanu S. Steel G. Hu C. A. Lin W. W. Willis A. (2005). Functional consequences of PRODH missense mutations. Am. J. Hum. Genet. 76 409–420. 10.1086/428142 15662599
Benias P. C. Wells R. G. Sackey-Aboagye B. Klavan H. Reidy J. Buonocore D. (2018). Structure and distribution of an unrecognized interstitium in human tissues. Sci. Rep. 8 :4947 .
Benincasa M. Pelillo C. Zorzet S. Garrovo C. Biffi S. Gennaro R. (2010). The proline-rich peptide Bac7(1-35) reduces mortality from Salmonella typhimurium in a mouse model of infection. BMC Microbiol. 10 :178 . 10.1186/1471-2180-10-178 20573188
Bertolo R. F. Burrin D. G. (2008). Comparative aspects of tissue glutamine and proline metabolism. J. Nutr. 138 2032S–2039S.18806120
Bevilacqua E. Bussolati O. Dall’asta V. Gaccioli F. Sala R. Gazzola G. C. (2005). SNAT2 silencing prevents the osmotic induction of transport system A and hinders cell recovery from hypertonic stress. FEBS Lett. 579 3376–3380. 10.1016/j.febslet.2005.05.002 15922329
Bhola P. T. Hartley T. Bareke E. Care4Rare Canada Consortium, Boycott K. M. Nikkel S. M. (2017). Autosomal dominant cutis laxa with progeroid features due to a novel, de novo mutation in ALDH18A1. J. Hum. Genet. 62 661–663. 10.1038/jhg.2017.18 28228640
Biancucci M. Mattioli R. Moubayidin L. Sabatini S. Costantino P. Trovato M. (2015). Proline affects the size of the root meristematic zone in Arabidopsis. BMC Plant Biol. 15 :263 . 10.1186/s12870-015-0637-8 26514776
Bicknell L. S. Pitt J. Aftimos S. Ramadas R. Maw M. A. Robertson S. P. (2008). A missense mutation in ALDH18A1, encoding Delta1-pyrroline-5-carboxylate synthase (P5CS), causes an autosomal recessive neurocutaneous syndrome. Eur. J. Hum. Genet. 16 1176–1186. 10.1038/ejhg.2008.91 18478038
Blake R. L. Russell E. S. (1972). Hyperprolinemia and prolinuria in a new inbred strain of mice. PRO-Re. Science 176 809–811. 10.1126/science.176.4036.809 5031477
Blaschke K. Ebata K. T. Karimi M. M. Zepeda-Martinez J. A. Goyal P. Mahapatra S. (2013). Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells. Nature 500 222–226. 10.1038/nature12362 23812591
Bringaud F. Barrett M. P. Zilberstein D. (2012). Multiple roles of proline transport and metabolism in trypanosomatids. Front. Biosci. (Landmark Ed) 17 :349–374. 10.2741/3931 22201748
Broer S. Bailey C. G. Kowalczuk S. Ng C. Vanslambrouck J. M. Rodgers H. (2008). Iminoglycinuria and hyperglycinuria are discrete human phenotypes resulting from complex mutations in proline and glycine transporters. J. Clin. Invest. 118 3881–3892. 10.1172/jci36625 19033659
Bulet P. Dimarcq J. L. Hetru C. Lagueux M. Charlet M. Hegy G. (1993). A novel inducible antibacterial peptide of Drosophila carries an O-glycosylated substitution. J. Biol. Chem. 268 14893–14897. 10.1016/s0021-9258(18)82417-6 8325867
Burg M. B. Ferraris J. D. Dmitrieva N. I. (2007). Cellular response to hyperosmotic stresses. Physiol. Rev. 87 1441–1474. 10.1152/physrev.00056.2006 17928589
Bursell E. (1975). Substrates of oxidative metabolism in dipteran flight muscle. Comp. Biochem. Physiol. B 52 235–238. 10.1016/0305-0491(75)90057-7 170034
Cai F. Miao Y. Liu C. Wu T. Shen S. Su X. (2018). Pyrroline-5-carboxylate reductase 1 promotes proliferation and inhibits apoptosis in non-small cell lung cancer. Oncol. Lett. 15 731–740.29403556
Campbell H. D. Webb G. C. Young I. G. (1997). A human homologue of the Drosophila melanogaster sluggish-A (proline oxidase) gene maps to 22q11.2, and is a candidate gene for type-I hyperprolinaemia. Hum. Genet. 101 69–74. 10.1007/s004390050589 9385373
Candy D. J. Becker A. Wegener G. (1997). Coordination and integration of metabolism in insect flight. Comp. Biochem. Physiol. Part B: Biochem. Mol. Biol. 117 :15 .
Canon F. Belloir C. Bourillot E. Brignot H. Briand L. Feron G. (2021). Perspectives on astringency sensation: an alternative hypothesis on the molecular origin of astringency. J. Agric. Food Chem. 69 3822–3826. 10.1021/acs.jafc.0c07474 33682421
Cao H. Ke T. Liu R. Yu J. Dong C. Cheng M. (2015). Identification of a novel proline-rich antimicrobial peptide from Brassica napus. PLoS One 10 :e0137414 . 10.1371/journal.pone.0137414 26383098
Cao N. Liu Z. Chen Z. Wang J. Chen T. Zhao X. (2012). Ascorbic acid enhances the cardiac differentiation of induced pluripotent stem cells through promoting the proliferation of cardiac progenitor cells. Cell Res. 22 219–236. 10.1038/cr.2011.195 22143566
Cappelletti P. Tallarita E. Rabattoni V. Campomenosi P. Sacchi S. Pollegioni L. (2018). Proline oxidase controls proline, glutamate, and glutamine cellular concentrations in a U87 glioblastoma cell line. PLoS One 13 :e0196283 . 10.1371/journal.pone.0196283 29694413
Casalino L. Comes S. Lambazzi G. De Stefano B. Filosa S. De Falco S. (2011). Control of embryonic stem cell metastability by L-proline catabolism. J. Mol. Cell Biol. 3 108–122. 10.1093/jmcb/mjr001 21307025
Casteels P. Ampe C. Jacobs F. Vaeck M. Tempst P. (1989). Apidaecins: antibacterial peptides from honeybees. EMBO J. 8 2387–2391. 10.1002/j.1460-2075.1989.tb08368.x 2676519
Cecchini N. M. Monteoliva M. I. Alvarez M. E. (2011). Proline dehydrogenase contributes to pathogen defense in Arabidopsis. Plant Physiol. 155 1947–1959. 10.1104/pp.110.167163 21311034
Cermola F. D’aniello C. Tate R. De Cesare D. Martinez-Arias A. Minchiotti G. (2021). Gastruloid development competence discriminates different states of pluripotency. Stem Cell Rep. 16 354–369. 10.1016/j.stemcr.2020.12.013 33482102
Chao J. R. Knight K. Engel A. L. Jankowski C. Wang Y. Manson M. A. (2017). Human retinal pigment epithelial cells prefer proline as a nutrient and transport metabolic intermediates to the retinal side. J. Biol. Chem. 292 12895–12905. 10.1074/jbc.m117.788422 28615447
Charon J. Manteca A. Innis C. A. (2019). Using the bacterial ribosome as a discovery platform for peptide-based antibiotics. Biochemistry 58 75–84. 10.1021/acs.biochem.8b00927 30372045
Chen C. Dickman M. B. (2005). Proline suppresses apoptosis in the fungal pathogen Colletotrichum trifolii. Proc. Natl. Acad. Sci. U S A. 102 3459–3464. 10.1073/pnas.0407960102 15699356
Chen S. Yang X. Yu M. Wang Z. Liu B. Liu M. (2019). SIRT3 regulates cancer cell proliferation through deacetylation of PYCR1 in proline metabolism. Neoplasia 21 665–675. 10.1016/j.neo.2019.04.008 31108370
Chen X. Li J. Sun H. Li S. Chen T. Liu G. (2017). High-level heterologous production and functional secretion by recombinant Pichia pastoris of the shortest proline-rich antibacterial honeybee peptide Apidaecin. Sci. Rep. 7 :14543 .
Choudhary S. Kishore N. Hosur R. V. (2015). Inhibition of insulin fibrillation by osmolytes: mechanistic insights. Sci. Rep. 5 :17599 .
Choudhary S. Save S. N. Kishore N. Hosur R. V. (2016). Synergistic inhibition of protein fibrillation by proline and sorbitol: biophysical investigations. PLoS One 11 :e0166487 . 10.1371/journal.pone.0166487 27870861
Chowdhury T. Mandal S. M. Dutta S. Ghosh A. K. (2021). Identification of a novel proline-rich antimicrobial protein from the hemolymph of Antheraea mylitta. Arch. Insect. Biochem. Physiol. 106 :e21771 .
Christgen S. L. Becker D. F. (2019). Role of proline in pathogen and host interactions. Antioxid. Redox. Signal. 30 683–709. 10.1089/ars.2017.7335 29241353
Chyzynska K. Labun K. Jones C. Grellscheid S. N. Valen E. (2021). Deep conservation of ribosome stall sites across RNA processing genes. NAR Genom Bioinform. 3 :lqab038 .
Clelland C. L. Read L. L. Baraldi A. N. Bart C. P. Pappas C. A. Panek L. J. (2011). Evidence for association of hyperprolinemia with schizophrenia and a measure of clinical outcome. Schizophr. Res. 131 139–145. 10.1016/j.schres.2011.05.006 21645996
Cociancich S. Dupont A. Hegy G. Lanot R. Holder F. Hetru C. (1994). Novel inducible antibacterial peptides from a hemipteran insect, the sap-sucking bug Pyrrhocoris apterus. Biochem. J. 300 (Pt 2) , 567–575. 10.1042/bj3000567 8002963
Cohen S. M. Nadler J. V. (1997). Proline-induced potentiation of glutamate transmission. Brain Res. 761 271–282. 10.1016/s0006-8993(97)00352-1 9252026
Comes S. Gagliardi M. Laprano N. Fico A. Cimmino A. Palamidessi A. (2013). L-Proline induces a mesenchymal-like invasive program in embryonic stem cells by remodeling H3K9 and H3K36 methylation. Stem Cell Rep. 1 307–321. 10.1016/j.stemcr.2013.09.001 24319666
Costantino P. Capone I. Cardarelli M. De Paolis A. Mauro M. L. Trovato M. (1994). Bacterial plant oncogenes: the rol genes’ saga. Genetica 94 203–211. 10.1007/bf01443434 7896140
Coulthard G. Erb W. Aggarwal V. K. (2012). Stereocontrolled organocatalytic synthesis of prostaglandin PGF2alpha in seven steps. Nature 489 278–281. 10.1038/nature11411 22895192
Coutelier M. Goizet C. Durr A. Habarou F. Morais S. Dionne-Laporte A. (2015). Alteration of ornithine metabolism leads to dominant and recessive hereditary spastic paraplegia. Brain 138 2191–2205.26026163
Crabtree G. W. Park A. J. Gordon J. A. Gogos J. A. (2016). Cytosolic accumulation of L-Proline disrupts GABA-Ergic transmission through GAD blockade. Cell Rep. 17 570–582. 10.1016/j.celrep.2016.09.029 27705802
Csonka L. N. Hanson A. D. (1991). Prokaryotic osmoregulation: genetics and physiology. Annu. Rev. Microbiol. 45 569–606. 10.1146/annurev.mi.45.100191.003033 1741624
Curi R. Newsholme P. Procopio J. Lagranha C. Gorjao R. Pithon-Curi T. C. (2007). Glutamine, gene expression, and cell function. Front. Biosci. 12 :344–357. 10.2741/2068 17127303
Cusan M. Vegi N. M. Mulaw M. A. Bamezai S. Kaiser L. M. Deshpande A. J. (2017). Controlled stem cell amplification by HOXB4 depends on its unique proline-rich region near the N terminus. Blood 129 319–323. 10.1182/blood-2016-04-706978 27827825
Dabrowa N. Taxer S. S. Howard D. H. (1976). Germination of Candida albicans induced by proline. Infect. Immun. 13 830–835. 10.1128/iai.13.3.830-835.1976 5375
D’Aniello C. Cermola F. Palamidessi A. Wanderlingh L. G. Gagliardi M. Migliaccio A. (2019a). Collagen Prolyl hydroxylation-dependent metabolic perturbation governs epigenetic remodeling and mesenchymal transition in pluripotent and Cancer cells. Cancer Res. 79 3235–3250. 10.1158/0008-5472.can-18-2070 31061065
D’Aniello C. Cermola F. Patriarca E. J. Minchiotti G. (2019b). Metabolic–Epigenetic axis in pluripotent state transitions. Epigenomes 3 :13 . 10.3390/epigenomes3030013
D’Aniello C. Cermola F. Patriarca E. J. Minchiotti G. (2017). Vitamin C in stem cell biology: impact on extracellular matrix homeostasis and epigenetics. Stem Cells Int. 2017 :8936156 .
D’Aniello C. Fico A. Casalino L. Guardiola O. Di Napoli G. Cermola F. (2015). A novel autoregulatory loop between the Gcn2-Atf4 pathway and (L)-Proline [corrected] metabolism controls stem cell identity. Cell Death Differ. 22 1094–1105. 10.1038/cdd.2015.24 25857264
D’Aniello C. Habibi E. Cermola F. Paris D. Russo F. Fiorenzano A. (2016). Vitamin C and l-Proline antagonistic effects capture alternative states in the pluripotency continuum. Stem Cell Rep. 8 1–10. 10.1016/j.stemcr.2016.11.011 28017658
D’Aniello C. Patriarca E. J. Phang J. M. Minchiotti G. (2020). Proline metabolism in tumor growth and metastatic progression. Front. Oncol. 10 :776 . 10.3389/fonc.2020.00776 32500033
de Barsy A. M. Moens E. Dierckx L. (1968). Dwarfism, oligophrenia and degeneration of the elastic tissue in skin and cornea. a new syndrome?. Helv. Paediatr. Acta 23 305–313.4302249
Deng Y. Zheng X. Zhang Y. Xu M. Ye C. Lin M. (2020). High SPRR1A expression is associated with poor survival in patients with colon cancer. Oncol. Lett. 19 3417–3424.32269614
Desbois-Mouthon C. Cadoret A. Blivet-Van Eggelpoel M. J. Bertrand F. Cherqui G. Perret C. (2001). Insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activation. Oncogene 20 252–259. 10.1038/sj.onc.1204064 11313952
Ding J. Kuo M. L. Su L. Xue L. Luh F. Zhang H. (2017). Human mitochondrial pyrroline-5-carboxylate reductase 1 promotes invasiveness and impacts survival in breast cancers. Carcinogenesis 38 519–531. 10.1093/carcin/bgx022 28379297
Ding Z. Ericksen R. E. Lee Q. Y. Han W. (2021). Reprogramming of mitochondrial proline metabolism promotes liver tumorigenesis. Amino Acids. Online ahead of print.
Disease G. B. D. Injury I. Prevalence C. (2017). Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390 1211–1259.28919117
Doerfel L. K. Wohlgemuth I. Kothe C. Peske F. Urlaub H. Rodnina M. V. (2013). EF-P is essential for rapid synthesis of proteins containing consecutive proline residues. Science 339 85–88. 10.1126/science.1229017 23239624
Dolashka P. Moshtanska V. Borisova V. Dolashki A. Stevanovic S. Dimanov T. (2011). Antimicrobial proline-rich peptides from the hemolymph of marine snail Rapana venosa. Peptides 32 1477–1483. 10.1016/j.peptides.2011.05.001 21703315
Dolezelova E. Kunzova M. Dejung M. Levin M. Panicucci B. Regnault C. (2020). Cell-based and multi-omics profiling reveals dynamic metabolic repurposing of mitochondria to drive developmental progression of Trypanosoma brucei. PLoS Biol. 18 :e3000741 . 10.1371/journal.pbio.3000741 32520929
Donald S. P. Sun X. Y. Hu C. A. Yu J. Mei J. M. Valle D. (2001). Proline oxidase, encoded by p53-induced gene-6, catalyzes the generation of proline-dependent reactive oxygen species. Cancer Res. 61 1810–1815.11280728
Dong X. Chang Y. Zheng R. Wang X. Yan X. Ma X. F. (2021). Phytoremediation of cadmium contaminated soil: impacts on morphological traits. proline content and stomata parameters of sweet sorghum seedlings. Bull. Environ. Contam. Toxicol. 106 528–535. 10.1007/s00128-021-03125-7 33661312
Du J. Zhu S. Lim R. R. Chao J. R. (2021). Proline metabolism and transport in retinal health and disease. Amino Acids. Online ahead of print.
Dubey S. Gupta A. Khare A. Jain G. Bose S. Rani V. (2018). Long- and short-term protective responses of rice seedling to combat Cr(VI) toxicity. Environ. Sci. Pollut. Res. Int. 25 36163–36172. 10.1007/s11356-018-3422-z 30362036
Dufourc E. J. (2021). Wine tannins, saliva proteins and membrane lipids. Biochim. Biophys. Acta Biomembr. 1863 :183670 . 10.1016/j.bbamem.2021.183670 34111413
Elia I. Broekaert D. Christen S. Boon R. Radaelli E. Orth M. F. (2017). Proline metabolism supports metastasis formation and could be inhibited to selectively target metastasizing cancer cells. Nat. Commun. 8 :15267 .
Elnagdi N. M. Al-Hokbany N. S. (2012). Organocatalysis in synthesis: L-proline as an enantioselective catalyst in the synthesis of pyrans and thiopyrans. Molecules 17 4300–4312. 10.3390/molecules17044300 22491679
Ensenat D. Hassan S. Reyna S. V. Schafer A. I. Durante W. (2001). Transforming growth factor-beta 1 stimulates vascular smooth muscle cell L-proline transport by inducing system a amino acid transporter 2 (SAT2) gene expression. Biochem. J. 360 507–512. 10.1042/bj3600507 11716780
Esteban M. A. Wang T. Qin B. Yang J. Qin D. Cai J. (2010). Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. Cell Stem Cell 6 71–79.20036631
Fabro G. Kovacs I. Pavet V. Szabados L. Alvarez M. E. (2004). Proline accumulation and AtP5CS2 gene activation are induced by plant-pathogen incompatible interactions in Arabidopsis. Mol. Plant Microbe Interact. 17 343–350. 10.1094/mpmi.2004.17.4.343 15077666
Faundes V. Jennings M. D. Crilly S. Legraie S. Withers S. E. Cuvertino S. (2021). Impaired eIF5A function causes a mendelian disorder that is partially rescued in model systems by spermidine. Nat. Commun. 12 :833 .
Ferreira A. G. Scherer E. B. Da Cunha A. A. Manfredini V. Biancini G. B. Vanzin C. S. (2014). Hyperprolinemia induces DNA, protein and lipid damage in blood of rats: antioxidant protection. Int. J. Biochem. Cell Biol. 54 20–25. 10.1016/j.biocel.2014.05.027 24980685
Fischer B. Callewaert B. Schroter P. Coucke P. J. Schlack C. Ott C. E. (2014). Severe congenital cutis laxa with cardiovascular manifestations due to homozygous deletions in ALDH18A1. Mol. Genet. Metab. 112 310–316. 10.1016/j.ymgme.2014.05.003 24913064
Fischer-Zirnsak B. Escande-Beillard N. Ganesh J. Tan Y. X. Al Bughaili M. Lin A. E. (2015). Recurrent de novo mutations affecting residue Arg138 of Pyrroline-5-Carboxylate synthase cause a progeroid form of autosomal-dominant cutis laxa. Am. J. Hum. Genet. 97 483–492. 10.1016/j.ajhg.2015.08.001 26320891
Florin T. Maracci C. Graf M. Karki P. Klepacki D. Berninghausen O. (2017). An antimicrobial peptide that inhibits translation by trapping release factors on the ribosome. Nat. Struct. Mol. Biol. 24 752–757. 10.1038/nsmb.3439 28741611
Forlani G. Sabbioni G. Ragno D. Petrollino D. Borgatti M. (2021). Phenyl-substituted aminomethylene-bisphosphonates inhibit human P5C reductase and show antiproliferative activity against proline-hyperproducing tumour cells. J. Enzyme. Inhib. Med. Chem. 36 1248–1257. 10.1080/14756366.2021.1919890 34107832
Francisco S. M. Tierney M. L. (1990). Isolation and characterization of a proline-rich cell wall protein from soybean seedlings. Plant Physiol. 94 1897–1902. 10.1104/pp.94.4.1897 16667932
Freimark D. Sehl C. Weber C. Hudel K. Czermak P. Hofmann N. (2011). Systematic parameter optimization of a Me(2)SO- and serum-free cryopreservation protocol for human mesenchymal stem cells. Cryobiology 63 67–75. 10.1016/j.cryobiol.2011.05.002 21620818
Fremeau R. T. Jr. Caron M. G. Blakely R. D. (1992). Molecular cloning and expression of a high affinity L-proline transporter expressed in putative glutamatergic pathways of rat brain. Neuron 8 915–926. 10.1016/0896-6273(92)90206-s 1350201
Gaccioli F. Huang C. C. Wang C. Bevilacqua E. Franchi-Gazzola R. Gazzola G. C. (2006). Amino acid starvation induces the SNAT2 neutral amino acid transporter by a mechanism that involves eukaryotic initiation factor 2alpha phosphorylation and cap-independent translation. J. Biol. Chem. 281 17929–17940. 10.1074/jbc.m600341200 16621798
Gagnon M. G. Roy R. N. Lomakin I. B. Florin T. Mankin A. S. Steitz T. A. (2016). Structures of proline-rich peptides bound to the ribosome reveal a common mechanism of protein synthesis inhibition. Nucleic Acids Res. 44 2439–2450. 10.1093/nar/gkw018 26809677
Gennaro R. Skerlavaj B. Romeo D. (1989). Purification, composition, and activity of two bactenecins, antibacterial peptides of bovine neutrophils. Infect. Immun. 57 3142–3146. 10.1128/iai.57.10.3142-3146.1989 2777377
Gennaro R. Zanetti M. Benincasa M. Podda E. Miani M. (2002). Pro-rich antimicrobial peptides from animals: structure, biological functions and mechanism of action. Curr. Pharm. Des. 8 763–778. 10.2174/1381612023395394 11945170
Geraghty M. T. Vaughn D. Nicholson A. J. Lin W. W. Jimenez-Sanchez G. Obie C. (1998). Mutations in the Delta1-pyrroline 5-carboxylate dehydrogenase gene cause type II hyperprolinemia. Hum. Mol. Genet. 7 1411–1415. 10.1093/hmg/7.9.1411 9700195
Gogos J. A. Santha M. Takacs Z. Beck K. D. Luine V. Lucas L. R. (1999). The gene encoding proline dehydrogenase modulates sensorimotor gating in mice. Nat. Genet. 21 434–439. 10.1038/7777 10192398
Goldstrohm D. A. Pennington J. E. Wells M. A. (2003). The role of hemolymph proline as a nitrogen sink during blood meal digestion by the mosquito Aedes aegypti. J. Insect Physiol. 49 115–121. 10.1016/s0022-1910(02)00267-6 12770004
Gonen N. Meller A. Sabath N. Shalgi R. (2019). Amino acid biosynthesis regulation during endoplasmic reticulum stress is coupled to protein expression demands. iScience 19 204–213. 10.1016/j.isci.2019.07.022 31377665
Graf M. Huter P. Maracci C. Peterek M. Rodnina M. V. Wilson D. N. (2018). Visualization of translation termination intermediates trapped by the Apidaecin 137 peptide during RF3-mediated recycling of RF1. Nat. Commun. 9 :3053 .
Graf M. Mardirossian M. Nguyen F. Seefeldt A. C. Guichard G. Scocchi M. (2017). Proline-rich antimicrobial peptides targeting protein synthesis. Nat. Prod. Rep. 34 702–711. 10.1039/c7np00020k 28537612
Graf M. Wilson D. N. (2019). Intracellular antimicrobial peptides targeting the protein synthesis machinery. Adv. Exp. Med. Biol. 1117 73–89. 10.1007/978-981-13-3588-4_6 30980354
Greene M. L. Lietman P. S. Rosenberg L. E. Seegmiller J. E. (1973). Familial hyperglycinuria. New defect in renal tubular transport of glycine and imino acids. Am. J. Med. 54 265–271.4685850
Guan J. Gluckman P. D. (2009). IGF-1 derived small neuropeptides and analogues: a novel strategy for the development of pharmaceuticals for neurological conditions. Br. J. Pharmacol. 157 881–891. 10.1111/j.1476-5381.2009.00256.x 19438508
Gueguen Y. Bernard R. Julie F. Paulina S. Delphine D. G. Franck V. (2009). Oyster hemocytes express a proline-rich peptide displaying synergistic antimicrobial activity with a defensin. Mol. Immunol. 46 516–522. 10.1016/j.molimm.2008.07.021 18962895
Guernsey D. L. Jiang H. Evans S. C. Ferguson M. Matsuoka M. Nightingale M. (2009). Mutation in pyrroline-5-carboxylate reductase 1 gene in families with cutis laxa type 2. Am. J. Hum. Genet. 85 120–129. 10.1016/j.ajhg.2009.06.008 19576563
Guo L. Cui C. Wang J. Yuan J. Yang Q. Zhang P. (2020). PINCH-1 regulates mitochondrial dynamics to promote proline synthesis and tumor growth. Nat. Commun. 11 :4913 .
Guo L. Cui C. Zhang K. Wang J. Wang Y. Lu Y. (2019). Kindlin-2 links mechano-environment to proline synthesis and tumor growth. Nat. Commun. 10 :845 .
Gutierrez E. Shin B. S. Woolstenhulme C. J. Kim J. R. Saini P. Buskirk A. R. (2013). eIF5A promotes translation of polyproline motifs. Mol. Cell 51 35–45. 10.1016/j.molcel.2013.04.021 23727016
Haindrich A. C. Ernst V. Naguleswaran A. Oliveres Q. F. Roditi I. Rentsch D. (2021). Nutrient availability regulates proline/alanine transporters in Trypanosoma brucei. J. Biol. Chem. 296 :100566 . 10.1016/j.jbc.2021.100566 33745971
Han J. Back S. H. Hur J. Lin Y. H. Gildersleeve R. Shan J. (2013). ER-stress-induced transcriptional regulation increases protein synthesis leading to cell death. Nat. Cell Biol. 15 481–490. 10.1038/ncb2738 23624402
Handa S. Bressan R. A. Handa A. K. Carpita N. C. Hasegawa P. M. (1983). Solutes contributing to osmotic adjustment in cultured plant cells adapted to water stress. Plant Physiol. 73 834–843. 10.1104/pp.73.3.834 16663309
Haudecoeur E. Planamente S. Cirou A. Tannieres M. Shelp B. J. Morera S. (2009). Proline antagonizes GABA-induced quenching of quorum-sensing in Agrobacterium tumefaciens. Proc. Natl. Acad. Sci. U S A. 106 14587–14592. 10.1073/pnas.0808005106 19706545
Hayat S. Hayat Q. Alyemeni M. N. Wani A. S. Pichtel J. Ahmad A. (2012). Role of proline under changing environments: a review. Plant Signal. Behav. 7 1456–1466. 10.4161/psb.21949 22951402
Hayward D. C. Delaney S. J. Campbell H. D. Ghysen A. Benzer S. Kasprzak A. B. (1993). The sluggish-A gene of Drosophila melanogaster is expressed in the nervous system and encodes proline oxidase, a mitochondrial enzyme involved in glutamate biosynthesis. Proc. Natl. Acad. Sci. U S A. 90 2979–2983. 10.1073/pnas.90.7.2979 8096642
He F. DiMario P. J. (2011). Drosophila delta-1-pyrroline-5-carboxylate dehydrogenase (P5CDh) is required for proline breakdown and mitochondrial integrity-Establishing a fly model for human type II hyperprolinemia. Mitochondrion 11 397–404. 10.1016/j.mito.2010.12.001 21168532
He W. Li P. Wu G. (2021). Amino acid nutrition and metabolism in chickens. Adv. Exp. Med. Biol. 1285 109–131. 10.1007/978-3-030-54462-1_7 33770405
Heljasvaara R. Aikio M. Ruotsalainen H. Pihlajaniemi T. (2017). Collagen XVIII in tissue homeostasis and dysregulation - lessons learned from model organisms and human patients. Matrix Biol. 57-58 55–75. 10.1016/j.matbio.2016.10.002 27746220
Hewitt S. N. Dranow D. M. Horst B. G. Abendroth J. A. Forte B. Hallyburton I. (2017). Biochemical and structural characterization of selective allosteric inhibitors of the plasmodium falciparum drug target, Prolyl-tRNA-synthetase. ACS Infect. Dis. 3 34–44.27798837
Hnilickova H. Kraus K. Vachova P. Hnilicka F. (2021). Salinity stress affects photosynthesis, malondialdehyde formation, and proline content in Portulaca oleracea L. Plants (Basel) 10 :845 . 10.3390/plants10050845 33922210
Hoffmann E. K. Lambert I. H. Pedersen S. F. (2009). Physiology of cell volume regulation in vertebrates. Physiol. Rev. 89 193–277. 10.1152/physrev.00037.2007 19126758
Hung J. J. Dear B. J. Dinin A. K. Borwankar A. U. Mehta S. K. Truskett T. T. (2018). Improving viscosity and stability of a highly concentrated monoclonal antibody solution with concentrated proline. Pharm. Res. 35 :133 .
Ignatova Z. Gierasch L. M. (2006). Inhibition of protein aggregation in vitro and in vivo by a natural osmoprotectant. Proc. Natl. Acad. Sci. U S A. 103 13357–13361. 10.1073/pnas.0603772103 16899544
Islam M. M. Hoque M. A. Okuma E. Banu M. N. Shimoishi Y. Nakamura Y. (2009). Exogenous proline and glycinebetaine increase antioxidant enzyme activities and confer tolerance to cadmium stress in cultured tobacco cells. J. Plant Physiol. 166 1587–1597. 10.1016/j.jplph.2009.04.002 19423184
Jacquet H. Berthelot J. Bonnemains C. Simard G. Saugier-Veber P. Raux G. (2003). The severe form of type I hyperprolinaemia results from homozygous inactivation of the PRODH gene. J. Med. Genet. 40 :e7 .
Jacquet H. Demily C. Houy E. Hecketsweiler B. Bou J. Raux G. (2005). Hyperprolinemia is a risk factor for schizoaffective disorder. Mol. Psychiatry 10 479–485. 10.1038/sj.mp.4001597 15494707
Jacquet H. Raux G. Thibaut F. Hecketsweiler B. Houy E. Demilly C. (2002). PRODH mutations and hyperprolinemia in a subset of schizophrenic patients. Hum. Mol. Genet. 11 2243–2249. 10.1093/hmg/11.19.2243 12217952
Jaksic T. Wagner D. A. Young V. R. (1990). Plasma proline kinetics and concentrations in young men in response to dietary proline deprivation. Am. J. Clin. Nutr. 52 307–312. 10.1093/ajcn/52.2.307 2375297
Jones B. Balasubramaniam M. Lebowitz J. J. Taylor A. Villalta F. Khoshbouei H. (2021). Activation of proline biosynthesis is critical to maintain glutamate homeostasis during acute methamphetamine exposure. Sci. Rep. 11 :1422 .
Jukkola A. Kauppila S. Risteli L. Vuopala K. Risteli J. Leisti J. (1998). New lethal disease involving type I and III collagen defect resembling geroderma osteodysplastica, De Barsy syndrome, and Ehlers-Danlos syndrome IV. J. Med. Genet. 35 513–518. 10.1136/jmg.35.6.513 9643297
Kanwar Y. S. Krakower C. A. Manaligod J. R. Justice P. Wong P. W. (1975). Biochemical, morphological and hybrid studies in hyperprolinemic mice. Biomedicine 22 209–216.240452
Karayiorgou M. Morris M. A. Morrow B. Shprintzen R. J. Goldberg R. Borrow J. (1995). Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. Proc. Natl. Acad. Sci. U S A. 92 7612–7616. 10.1073/pnas.92.17.7612 7644464
Kardos G. R. Gowda R. Dinavahi S. S. Kimball S. Robertson G. P. (2020). Salubrinal in combination with 4E1RCat synergistically impairs melanoma development by disrupting the protein synthetic machinery. Front. Oncol. 10 :834 . 10.3389/fonc.2020.00834 32637352
Kardos G. R. Wastyk H. C. Robertson G. P. (2015). Disruption of proline synthesis in melanoma inhibits protein production mediated by the GCN2 pathway. Mol. Cancer Res. 13 1408–1420. 10.1158/1541-7786.mcr-15-0048 26082174
Kaur R. Paria P. Saini A. G. Suthar R. Bhatia V. Attri S. V. (2021). Metabolic epilepsy in hyperprolinemia type II due to a novel nonsense ALDH4A1 gene variant. Metab. Brain Dis. 36 1413–1417. 10.1007/s11011-021-00757-w 34037900
Khan S. H. Ahmad N. Ahmad F. Kumar R. (2010). Naturally occurring organic osmolytes: from cell physiology to disease prevention. IUBMB Life 62 891–895. 10.1002/iub.406 21190292
Kieliszewski M. J. Lamport D. T. (1994). Extensin: repetitive motifs, functional sites, post-translational codes, and phylogeny. Plant J. 5 157–172. 10.1046/j.1365-313x.1994.05020157.x 8148875
Killiny N. Hijaz F. El-Shesheny I. Alfaress S. Jones S. E. Rogers M. E. (2017). Metabolomic analyses of the haemolymph of the Asian citrus psyllid Diaphorina citri, the vector of huanglongbing. Physiol. Entomol. 42 134–145. 10.1111/phen.12183
Kleta R. Romeo E. Ristic Z. Ohura T. Stuart C. Arcos-Burgos M. (2004). Mutations in SLC6A19, encoding B0AT1, cause Hartnup disorder. Nat. Genet. 36 999–1002. 10.1038/ng1405 15286787
Knappe D. Piantavigna S. Hansen A. Mechler A. Binas A. Nolte O. (2010). Oncocin (VDKPPYLPRPRPPRRIYNR-NH2): a novel antibacterial peptide optimized against gram-negative human pathogens. J. Med. Chem. 53 5240–5247. 10.1021/jm100378b 20565063
Komatsu T. Kobayashi K. Morimoto Y. Helmerhorst E. Oppenheim F. Chang-Il Lee M. (2020). Direct evaluation of the antioxidant properties of salivary proline-rich proteins. J. Clin. Biochem. Nutr. 67 131–136. 10.3164/jcbn.19-75 33041509
Kostal V. Korbelova J. Poupardin R. Moos M. Simek P. (2016). Arginine and proline applied as food additives stimulate high freeze tolerance in larvae of Drosophila melanogaster. J. Exp. Biol. 219 2358–2367. 10.1242/jeb.142158 27489218
Kostal V. Simek P. Zahradnickova H. Cimlova J. Stetina T. (2012). Conversion of the chill susceptible fruit fly larva (Drosophila melanogaster) to a freeze tolerant organism. Proc. Natl. Acad. Sci. U S A. 109 3270–3274. 10.1073/pnas.1119986109 22331891
Kostal V. Zahradnickova H. Simek P. (2011). Hyperprolinemic larvae of the drosophilid fly, Chymomyza costata, survive cryopreservation in liquid nitrogen. Proc. Natl. Acad. Sci. U S A. 108 13041–13046. 10.1073/pnas.1107060108 21788482
Kragol G. Hoffmann R. Chattergoon M. A. Lovas S. Cudic M. Bulet P. (2002). Identification of crucial residues for the antibacterial activity of the proline-rich peptide, pyrrhocoricin. Eur. J. Biochem. 269 4226–4237. 10.1046/j.1432-1033.2002.03119.x 12199701
Kretz R. Bozorgmehr B. Kariminejad M. H. Rohrbach M. Hausser I. Baumer A. (2011). Defect in proline synthesis: pyrroline-5-carboxylate reductase 1 deficiency leads to a complex clinical phenotype with collagen and elastin abnormalities. J. Inherit. Metab. Dis. 34 731–739. 10.1007/s10545-011-9319-3 21487760
Krishnan N. Dickman M. B. Becker D. F. (2008). Proline modulates the intracellular redox environment and protects mammalian cells against oxidative stress. Free Radic. Biol. Med. 44 671–681. 10.1016/j.freeradbiomed.2007.10.054 18036351
Krizsan A. Prahl C. Goldbach T. Knappe D. Hoffmann R. (2015). Short Proline-Rich antimicrobial peptides inhibit either the bacterial 70S ribosome or the assembly of its large 50S subunit. Chembiochem 16 2304–2308. 10.1002/cbic.201500375 26448548
Krokowski D. Guan B. J. Wu J. Zheng Y. Pattabiraman P. P. Jobava R. (2017). GADD34 function in protein trafficking promotes adaptation to hyperosmotic stress in human corneal cells. Cell Rep. 21 2895–2910. 10.1016/j.celrep.2017.11.027 29212034
Lahiri V. Hawkins W. D. Klionsky D. J. (2019). Watch what you (Self-) eat: autophagic mechanisms that modulate metabolism. Cell Metab. 29 803–826. 10.1016/j.cmet.2019.03.003 30943392
Lamport D. T. Kieliszewski M. J. Chen Y. Cannon M. C. (2011). Role of the extensin superfamily in primary cell wall architecture. Plant Physiol. 156 11–19. 10.1104/pp.110.169011 21415277
Law R. O. (1991). Amino acids as volume-regulatory osmolytes in mammalian cells. Comp. Biochem. Physiol. A Comp. Physiol. 99 263–277. 10.1016/0300-9629(91)90001-s 1678326
Lehmann S. Funck D. Szabados L. Rentsch D. (2010). Proline metabolism and transport in plant development. Amino Acids 39 949–962. 10.1007/s00726-010-0525-3 20204435
Lenci E. Angeli A. Calugi L. Innocenti R. Carta F. Supuran C. T. (2021). Multitargeting application of proline-derived peptidomimetics addressing cancer-related human matrix metalloproteinase 9 and carbonic anhydrase II. Eur. J. Med. Chem. 214 :113260 . 10.1016/j.ejmech.2021.113260 33581552
Levashina E. A. Ohresser S. Bulet P. Reichhart J. M. Hetru C. Hoffmann J. A. (1995). Metchnikowin, a novel immune-inducible proline-rich peptide from Drosophila with antibacterial and antifungal properties. Eur. J. Biochem. 233 694–700. 10.1111/j.1432-1033.1995.694_2.x 7588819
Levine M. (1959). A new method for isolation of hydroxy-L-proline and L-proline from gelatin. J. Biol. Chem. 234 1731–1732. 10.1016/s0021-9258(18)69916-8 13672954
Li N. Yu J. Yang F. Shao Y. Wu S. Liu B. (2021). L-Proline: an effective agent for frozen and post-thawed donkey semen storage. J. Equine Vet. Sci. 101 :103393 . 10.1016/j.jevs.2021.103393 33993948
Li P. Wu G. (2018). Roles of dietary glycine, proline, and hydroxyproline in collagen synthesis and animal growth. Amino Acids 50 29–38. 10.1007/s00726-017-2490-6 28929384
Li W. F. Ma G. X. Zhou X. X. (2006). Apidaecin-type peptides: biodiversity, structure-function relationships and mode of action. Peptides 27 2350–2359. 10.1016/j.peptides.2006.03.016 16675061
Liang G. Taranova O. Xia K. Zhang Y. (2010). Butyrate promotes induced pluripotent stem cell generation. J. Biol. Chem. 285 25516–25521. 10.1074/jbc.m110.142059 20554530
Liang X. Dickman M. B. Becker D. F. (2014). Proline biosynthesis is required for endoplasmic reticulum stress tolerance in Saccharomyces cerevisiae. J. Biol. Chem. 289 27794–27806. 10.1074/jbc.m114.562827 25112878
Liang X. Zhang L. Natarajan S. K. Becker D. F. (2013). Proline mechanisms of stress survival. Antioxid. Redox. Signal. 19 998–1011. 10.1089/ars.2012.5074 23581681
Lin D. S. Chang J. H. Liu H. L. Wei C. H. Yeung C. Y. Ho C. S. (2011). Compound heterozygous mutations in PYCR1 further expand the phenotypic spectrum of De Barsy syndrome. Am. J. Med. Genet. A 155A 3095–3099. 10.1002/ajmg.a.34326 22052856
Lin H. V. Efanov A. M. Fang X. Beavers L. S. Wang X. Wang J. (2016). GPR142 controls tryptophan-induced insulin and incretin hormone secretion to improve glucose metabolism. PLoS One 11 :e0157298 . 10.1371/journal.pone.0157298 27322810
Linde C. M. Hoffner S. E. Refai E. Andersson M. (2001). . In vitro activity of PR-39, a proline-arginine-rich peptide, against susceptible and multi-drug-resistant Mycobacterium tuberculosis. J. Antimicrob. Chemother 47 575–580. 10.1093/jac/47.5.575 11328767
Linder S. Castanos-Velez E. Von Rosen A. Biberfeld P. (2001). Immunohistochemical expression of extracellular matrix proteins and adhesion molecules in pancreatic carcinoma. Hepatogastroenterology 48 1321–1327.11677955
List B. Castello C. (2001). A novel proline-catalyzed three-component reaction of ketones, aldehydes, and Meldrum’s acid. Synlett 1687–1689. 10.1055/s-2001-18095
List B. Hoang L. Martin H. J. (2004). New mechanistic studies on the proline-catalyzed aldol reaction. Proc. Natl. Acad. Sci. U S A. 101 5839–5842. 10.1073/pnas.0307979101 15073330
Liu H. Heath S. C. Sobin C. Roos J. L. Galke B. L. Blundell M. L. (2002). Genetic variation at the 22q11 PRODH2/DGCR6 locus presents an unusual pattern and increases susceptibility to schizophrenia. Proc. Natl. Acad. Sci. U S A. 99 3717–3722. 10.1073/pnas.042700699 11891283
Liu N. Dai Z. Zhang Y. Chen J. Yang Y. Wu G. (2019). Maternal L-proline supplementation enhances fetal survival, placental development, and nutrient transport in micedagger. Biol. Reprod. 100 1073–1081. 10.1093/biolre/ioy240 30418498
Liu N. Yang Y. Si X. Jia H. Zhang Y. Jiang D. (2021). L-Proline activates mammalian target of rapamycin complex 1 and modulates redox environment in porcine trophectoderm cells. Biomolecules 11 :742 . 10.3390/biom11050742 34067570
Liu W. Glunde K. Bhujwalla Z. M. Raman V. Sharma A. Phang J. M. (2012a). Proline oxidase promotes tumor cell survival in hypoxic tumor microenvironments. Cancer Res. 72 3677–3686. 10.1158/0008-5472.can-12-0080 22609800
Liu W. Le A. Hancock C. Lane A. N. Dang C. V. Fan T. W. (2012b). Reprogramming of proline and glutamine metabolism contributes to the proliferative and metabolic responses regulated by oncogenic transcription factor c-MYC. Proc. Natl. Acad. Sci. U S A. 109 8983–8988. 10.1073/pnas.1203244109 22615405
Liu Y. Borchert G. L. Donald S. P. Diwan B. A. Anver M. Phang J. M. (2009). Proline oxidase functions as a mitochondrial tumor suppressor in human cancers. Cancer Res. 69 6414–6422. 10.1158/0008-5472.can-09-1223 19654292
Liu Y. Borchert G. L. Surazynski A. Hu C. A. Phang J. M. (2006). Proline oxidase activates both intrinsic and extrinsic pathways for apoptosis: the role of ROS/superoxides, NFAT and MEK/ERK signaling. Oncogene 25 5640–5647. 10.1038/sj.onc.1209564 16619034
Liu Y. Borchert G. L. Surazynski A. Phang J. M. (2008). Proline oxidase, a p53-induced gene, targets COX-2/PGE2 signaling to induce apoptosis and inhibit tumor growth in colorectal cancers. Oncogene 27 6729–6737. 10.1038/onc.2008.322 18794809
Loayza-Puch F. Rooijers K. Buil L. C. Zijlstra J. Oude Vrielink J. F. Lopes R. (2016). Tumour-specific proline vulnerability uncovered by differential ribosome codon reading. Nature 530 490–494. 10.1038/nature16982 26878238
Loh Y. H. Zhang W. Chen X. George J. Ng H. H. (2007). Jmjd1a and Jmjd2c histone H3 Lys 9 demethylases regulate self-renewal in embryonic stem cells. Genes Dev. 21 2545–2557. 10.1101/gad.1588207 17938240
Lorenzo-Pouso A. I. Perez-Sayans M. Bravo S. B. Lopez-Jornet P. Garcia-Vence M. Alonso-Sampedro M. (2018). Protein-Based salivary profiles as novel biomarkers for oral diseases. Dis. Markers 2018 :6141845 .
Lu F. Liu Y. Jiang L. Yamaguchi S. Zhang Y. (2014). Role of tet proteins in enhancer activity and telomere elongation. Genes Dev. 28 2103–2119. 10.1101/gad.248005.114 25223896
Luo Y. Luo Y. Chang J. Xiao Z. Zhou B. (2020). Identification of candidate biomarkers and pathways associated with psoriasis using bioinformatics analysis. Hereditas 157 :30 .
Mackintosh J. A. Veal D. A. Beattie A. J. Gooley A. A. (1998). Isolation from an ant Myrmecia gulosa of two inducible O-glycosylated proline-rich antibacterial peptides. J. Biol. Chem. 273 6139–6143. 10.1074/jbc.273.11.6139 9497332
Magini P. Marco-Marin C. Escamilla-Honrubia J. M. Martinelli D. Dionisi-Vici C. Faravelli F. (2019). P5CS expression study in a new family with ALDH18A1-associated hereditary spastic paraplegia SPG9. Ann. Clin. Transl. Neurol. 6 1533–1540.31402623
Majesky M. W. Lindner V. Twardzik D. R. Schwartz S. M. Reidy M. A. (1991). Production of transforming growth factor beta 1 during repair of arterial injury. J. Clin. Invest. 88 904–910. 10.1172/jci115393 1832175
Malandro M. S. Kilberg M. S. (1996). Molecular biology of mammalian amino acid transporters. Annu. Rev. Biochem. 65 305–336. 10.1146/annurev.bi.65.070196.001513 8811182
Mali P. Chou B. K. Yen J. Ye Z. Zou J. Dowey S. (2010). Butyrate greatly enhances derivation of human induced pluripotent stem cells by promoting epigenetic remodeling and the expression of pluripotency-associated genes. Stem Cells 28 713–720. 10.1002/stem.402 20201064
Mandal A. Mandal S. Park M. H. (2014). Genome-wide analyses and functional classification of proline repeat-rich proteins: potential role of eIF5A in eukaryotic evolution. PLoS One 9 :e111800 . 10.1371/journal.pone.0111800 25364902
Mantilla B. S. Marchese L. Casas-Sanchez A. Dyer N. A. Ejeh N. Biran M. (2017). Proline metabolism is essential for trypanosoma Brucei brucei survival in the tsetse vector. PLoS Pathog 13 :e1006158 . 10.1371/journal.ppat.1006158 28114403
Mantilla B. S. Paes L. S. Pral E. M. Martil D. E. Thiemann O. H. Fernandez-Silva P. (2015). Role of Delta1-pyrroline-5-carboxylate dehydrogenase supports mitochondrial metabolism and host-cell invasion of Trypanosoma cruzi. J. Biol. Chem. 290 7767–7790. 10.1074/jbc.m114.574525 25623067
Mardirossian M. Barriere Q. Timchenko T. Muller C. Pacor S. Mergaert P. (2018a). Fragments of the non-lytic proline-rich antimicrobial peptide Bac5 kill E. coli cells by inhibiting protein synthesis. Antimicrob Agents Chemother. 62 :e00534-18 .
Mardirossian M. Perebaskine N. Benincasa M. Gambato S. Hofmann S. Huter P. (2018b). The dolphin proline-rich antimicrobial peptide Tur1A inhibits protein synthesis by targeting the bacterial ribosome. Cell Chem. Biol. 25 530–539.e7.29526712
Mardirossian M. Grzela R. Giglione C. Meinnel T. Gennaro R. Mergaert P. (2014). The host antimicrobial peptide Bac71-35 binds to bacterial ribosomal proteins and inhibits protein synthesis. Chem. Biol. 21 1639–1647. 10.1016/j.chembiol.2014.10.009 25455857
Martins R. M. Covarrubias C. Rojas R. G. Silber A. M. Yoshida N. (2009). Use of L-proline and ATP production by Trypanosoma cruzi metacyclic forms as requirements for host cell invasion. Infect. Immun. 77 3023–3032. 10.1128/iai.00138-09 19433547
Marvin K. W. George M. D. Fujimoto W. Saunders N. A. Bernacki S. H. Jetten A. M. (1992). Cornifin, a cross-linked envelope precursor in keratinocytes that is down-regulated by retinoids. Proc. Natl. Acad. Sci. U S A. 89 11026–11030. 10.1073/pnas.89.22.11026 1438308
Mateos B. Conrad-Billroth C. Schiavina M. Beier A. Kontaxis G. Konrat R. (2020). The ambivalent role of proline residues in an intrinsically disordered protein: from disorder promoters to compaction facilitators. J. Mol. Biol. 432 3093–3111. 10.1016/j.jmb.2019.11.015 31794728
Matsumoto K. Yamazaki K. Kawakami S. Miyoshi D. Ooi T. Hashimoto S. (2017). In vivo target exploration of apidaecin based on acquired resistance induced by gene overexpression (ARGO assay). Sci. Rep. 7 :12136 .
Mattioli R. Costantino P. Trovato M. (2009). Proline accumulation in plants: not only stress. Plant Signal. Behav. 4 1016–1018. 10.4161/psb.4.11.9797 20009553
Mattiuzzo M. Bandiera A. Gennaro R. Benincasa M. Pacor S. Antcheva N. (2007). Role of the Escherichia coli SbmA in the antimicrobial activity of proline-rich peptides. Mol. Microbiol. 66 151–163. 10.1111/j.1365-2958.2007.05903.x 17725560
Mazzalupo S. Isoe J. Belloni V. Scaraffia P. Y. (2016). Effective disposal of nitrogen waste in blood-fed Aedes aegypti mosquitoes requires alanine aminotransferase. FASEB J. 30 111–120. 10.1096/fj.15-277087 26310269
Melis M. Mastinu M. Pintus S. Cabras T. Crnjar R. Tomassini Barbarossa I. (2021). Differences in salivary proteins as a function of PROP taster status and gender in normal weight and obese subjects. Molecules 26 :2244 . 10.3390/molecules26082244 33924512
Memmott S. D. Ha Y. S. Dickman M. B. (2002). Proline reverses the abnormal phenotypes of Colletotrichum trifolii associated with expression of endogenous constitutively active Ras. Appl. Environ. Microbiol. 68 1647–1651. 10.1128/aem.68.4.1647-1651.2002 11916680
Messana I. Cabras T. Iavarone F. Manconi B. Huang L. Martelli C. (2015). Chrono-proteomics of human saliva: variations of the salivary proteome during human development. J. Proteome Res. 14 1666–1677. 10.1021/pr501270x 25761918
Michalkova V. Benoit J. B. Weiss B. L. Attardo G. M. Aksoy S. (2014). Vitamin B6 generated by obligate symbionts is critical for maintaining proline homeostasis and fecundity in tsetse flies. Appl. Environ. Microbiol. 80 5844–5853. 10.1128/aem.01150-14 25038091
Mishra A. K. Choi J. Moon E. Baek K. H. (2018). Tryptophan-Rich and proline-rich antimicrobial peptides. Molecules 23 :815 . 10.3390/molecules23040815 29614844
Mizushige T. Nogimura D. Nagai A. Mitsuhashi H. Taga Y. Kusubata M. (2019). Ginger-Degraded Collagen hydrolysate exhibits antidepressant activity in mice. J. Nutr. Sci. Vitaminol. (Tokyo) 65 251–257. 10.3177/jnsv.65.251 31257265
Moloney J. N. Cotter T. G. (2018). ROS signalling in the biology of cancer. Semin. Cell Dev. Biol. 80 50–64. 10.1016/j.semcdb.2017.05.023 28587975
Morgan A. A. Rubenstein E. (2013). Proline: the distribution, frequency, positioning, and common functional roles of proline and polyproline sequences in the human proteome. PLoS One 8 :e53785 . 10.1371/journal.pone.0053785 23372670
Morris M. B. Ozsoy S. Zada M. Zada M. Zamfirescu R. C. Todorova M. G. (2020). Selected amino acids promote mouse pre-implantation embryo development in a growth factor-like manner. Front. Physiol. 11 :140 . 10.3389/fphys.2020.00140 32210831
Murray-Stewart T. R. Woster P. M. Casero R. A. Jr. (2016). Targeting polyamine metabolism for cancer therapy and prevention. Biochem. J. 473 2937–2953. 10.1042/bcj20160383 27679855
Nadler J. V. Wang A. Hakim A. (1988). Toxicity of L-proline toward rat hippocampal neurons. Brain Res. 456 168–172. 10.1016/0006-8993(88)90358-7 3409032
Nagaoka A. Kunii Y. Hino M. Izumi R. Nagashima C. Takeshima A. (2020). ALDH4A1 expression levels are elevated in postmortem brains of patients with schizophrenia and are associated with genetic variants in enzymes related to proline metabolism. J. Psychiatr. Res. 123 119–127. 10.1016/j.jpsychires.2020.02.001 32065947
Nagesh P. K. B. Hatami E. Chowdhury P. Kashyap V. K. Khan S. Hafeez B. B. (2018). Tannic acid induces endoplasmic reticulum stress-mediated apoptosis in Prostate cancer. Cancers (Basel) 10 :68 . 10.3390/cancers10030068 29518944
Nakayama T. Al-Maawali A. El-Quessny M. Rajab A. Khalil S. Stoler J. M. (2015). Mutations in PYCR2, encoding Pyrroline-5-Carboxylate reductase 2, cause microcephaly and hypomyelination. Am. J. Hum. Genet. 96 709–719. 10.1016/j.ajhg.2015.03.003 25865492
Nam S. Y. Yoou M. S. Kim H. M. Jeong H. J. (2016). Efficacy of proline in the treatment of menopause. Exp. Biol. Med. (Maywood) 241 611–619. 10.1177/1535370216629011 26830682
Napierala J. S. Li Y. Lu Y. Lin K. Hauser L. A. Lynch D. R. (2017). Comprehensive analysis of gene expression patterns in Friedreich’s ataxia fibroblasts by RNA sequencing reveals altered levels of protein synthesis factors and solute carriers. Dis. Model Mech. 10 1353–1369. 10.1242/dmm.030536 29125828
Natarajan S. K. Zhu W. Liang X. Zhang L. Demers A. J. Zimmerman M. C. (2012). Proline dehydrogenase is essential for proline protection against hydrogen peroxide-induced cell death. Free Radic. Biol. Med. 53 1181–1191. 10.1016/j.freeradbiomed.2012.07.002 22796327
Nilsson R. Jain M. Madhusudhan N. Sheppard N. G. Strittmatter L. Kampf C. (2014). Metabolic enzyme expression highlights a key role for MTHFD2 and the mitochondrial folate pathway in cancer. Nat. Commun. 5 :3128 .
Nishida I. Watanabe D. Takagi H. (2016). Putative mitochondrial alpha-ketoglutarate-dependent dioxygenase Fmp12 controls utilization of proline as an energy source in Saccharomyces cerevisiae. Microb Cell 3 522–528. 10.15698/mic2016.10.535 28357320
Nogimura D. Mizushige T. Taga Y. Nagai A. Shoji S. Azuma N. (2020). Prolyl-hydroxyproline, a collagen-derived dipeptide, enhances hippocampal cell proliferation, which leads to antidepressant-like effects in mice. FASEB J. 34 5715–5723. 10.1096/fj.201902871r 32115749
Ogawa-Ohnishi M. Matsushita W. Matsubayashi Y. (2013). Identification of three hydroxyproline O-arabinosyltransferases in Arabidopsis thaliana. Nat. Chem. Biol. 9 726–730. 10.1038/nchembio.1351 24036508
Olivares O. Mayers J. R. Gouirand V. Torrence M. E. Gicquel T. Borge L. (2017). Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions. Nat. Commun. 8 :16031 .
Oscilowska I. Huynh T. Y. L. Baszanowska W. Prokop I. Surazynski A. Galli M. (2021). Proline oxidase silencing inhibits p53-dependent apoptosis in MCF-7 breast cancer cells. Amino Acids. Online ahead of print.
Pangborn C. A. Athanasiou K. A. (2005). Effects of growth factors on meniscal fibrochondrocytes. Tissue Eng. 11 1141–1148. 10.1089/ten.2005.11.1141 16144450
Panza E. Escamilla-Honrubia J. M. Marco-Marin C. Gougeard N. De Michele G. Morra V. B. (2016). ALDH18A1 gene mutations cause dominant spastic paraplegia SPG9: loss of function effect and plausibility of a dominant negative mechanism. Brain 139 :e3 . 10.1093/brain/awv247 26297558
Papu S. Berli F. Piccoli P. Paton D. Ortega Rodriguez D. R. Roig F. A. (2021). Physiological, biochemical, and anatomical responses of Araucaria araucana seedlings to controlled water restriction. Plant Physiol. Biochem. 165 47–56. 10.1016/j.plaphy.2021.05.005 34034160
Patel S. M. Seravalli J. Liang X. Tanner J. J. Becker D. F. (2021). Disease variants of human Delta(1)-pyrroline-5-carboxylate reductase 2 (PYCR2). Arch. Biochem. Biophys. 703 :108852 . 10.1016/j.abb.2021.108852 33771508
Patel V. K. Srivastava R. Sharma A. Srivastava A. K. Singh S. Srivastava A. K. (2018). Halotolerant Exiguobacterium profundum PHM11 tolerate salinity by accumulating L-Proline and fine-tuning gene expression profiles of related metabolic pathways. Front. Microbiol. 9 :423 . 10.3389/fmicb.2018.00423 29662469
Paterlini M. Zakharenko S. S. Lai W. S. Qin J. Zhang H. Mukai J. (2005). Transcriptional and behavioral interaction between 22q11.2 orthologs modulates schizophrenia-related phenotypes in mice. Nat. Neurosci. 8 1586–1594. 10.1038/nn1562 16234811
Pejam F. Ardebili Z. O. Ladan-Moghadam A. Danaee E. (2021). Zinc oxide nanoparticles mediated substantial physiological and molecular changes in tomato. PLoS One 16 :e0248778 . 10.1371/journal.pone.0248778 33750969
Pelss A. Gandhamsetty N. Smith J. R. Mailhol D. Silvi M. Watson A. (2018). Re-optimization of the organocatalyzed double aldol domino process to a key enal intermediate and its application to the total synthesis of Delta(1)(2)-Prostaglandin J(3). Chemistry 24 9542–9545. 10.1002/chem.201802498 29774967
Pemberton T. A. Still B. R. Christensen E. M. Singh H. Srivastava D. Tanner J. J. (2012). Proline: mother Nature’s cryoprotectant applied to protein crystallography. Acta Crystallogr. D. Biol. Crystallogr. 68 1010–1018. 10.1107/s0907444912019580 22868767
Phang J. M. (2019). Proline metabolism in cell regulation and cancer biology: recent advances and hypotheses. Antioxid. Redox. Signal. 30 635–649. 10.1089/ars.2017.7350 28990419
Pines M. Spector I. (2015). Halofuginone - the multifaceted molecule. Molecules 20 573–594. 10.3390/molecules20010573 25569515
Polyak K. Xia Y. Zweier J. L. Kinzler K. W. Vogelstein B. (1997). A model for p53-induced apoptosis. Nature 389 300–305.9305847
Powers E. T. Morimoto R. I. Dillin A. Kelly J. W. Balch W. E. (2009). Biological and chemical approaches to diseases of proteostasis deficiency. Annu. Rev. Biochem. 78 959–991. 10.1146/annurev.biochem.052308.114844 19298183
Prajapati K. P. Panigrahi A. Purohit S. Ansari M. Dubey K. Behera R. K. (2021). Osmoprotectant coated thermostable gold nanoparticles efficiently restrict temperature-induced amyloid aggregation of insulin. J. Phys. Chem. Lett. 12 1803–1813. 10.1021/acs.jpclett.0c03492 33577334
Psychogios N. Hau D. D. Peng J. Guo A. C. Mandal R. Bouatra S. (2011). The human serum metabolome. PLoS One 6 :e16957 . 10.1371/journal.pone.0016957 21359215
Pure E. Blomberg R. (2018). Pro-tumorigenic roles of fibroblast activation protein in cancer: back to the basics. Oncogene 37 4343–4357. 10.1038/s41388-018-0275-3 29720723
Qiao Y. Cai H. L. Yang X. Zang Y. Y. Chen Z. G. (2018). Effects of natural deep eutectic solvents on lactic acid bacteria viability during cryopreservation. Appl. Microbiol. Biotechnol. 102 5695–5705. 10.1007/s00253-018-8996-3 29737394
Qin P. Arabacilar P. Bernard R. E. Bao W. Olzinski A. R. Guo Y. (2017). Activation of the amino acid response pathway blunts the effects of cardiac stress. J. Am. Heart Assoc. 6 :e004453 .
Qin Q. Zhao L. Liu Z. Liu T. Qu J. Zhang X. (2020). Bioinspired l-Proline oligomers for the cryopreservation of oocytes via controlling ice growth. ACS Appl. Mater. Interfaces 12 18352–18362. 10.1021/acsami.0c02719 32227894
Rance G. A. Khlobystov A. N. (2014). The effects of interactions between proline and carbon nanostructures on organocatalysis in the Hajos-Parrish-Eder-Sauer-Wiechert reaction. Nanoscale 6 11141–11146. 10.1039/c4nr04009k 25213437
Raux G. Bumsel E. Hecketsweiler B. Van Amelsvoort T. Zinkstok J. Manouvrier-Hanu S. (2007). Involvement of hyperprolinemia in cognitive and psychiatric features of the 22q11 deletion syndrome. Hum. Mol. Genet. 16 83–91. 10.1093/hmg/ddl443 17135275
Reid M. A. Dai Z. Locasale J. W. (2017). The impact of cellular metabolism on chromatin dynamics and epigenetics. Nat. Cell Biol. 19 1298–1306. 10.1038/ncb3629 29058720
Reversade B. Escande-Beillard N. Dimopoulou A. Fischer B. Chng S. C. Li Y. (2009). Mutations in PYCR1 cause cutis laxa with progeroid features. Nat. Genet. 41 1016–1021.19648921
Roigaard-Petersen H. Sheikh M. I. (1984). Renal transport of neutral amino acids. Demonstration of Na+-independent and Na+-dependent electrogenic uptake of L-proline, hydroxy-L-proline and 5-oxo-L-proline by luminal-membrane vesicles. Biochem. J. 220 25–33. 10.1042/bj2200025 6743264
Roncevic T. Cikes-Culic V. Maravic A. Capanni F. Gerdol M. Pacor S. (2020). Identification and functional characterization of the astacidin family of proline-rich host defence peptides (PcAst) from the red swamp crayfish (Procambarus clarkii, Girard 1852). Dev. Comp. Immunol. 105 :103574 . 10.1016/j.dci.2019.103574 31884202
Roy R. N. Lomakin I. B. Gagnon M. G. Steitz T. A. (2015). The mechanism of inhibition of protein synthesis by the proline-rich peptide oncocin. Nat. Struct. Mol. Biol. 22 466–469. 10.1038/nsmb.3031 25984972
Rozsypal J. Moos M. Simek P. Kostal V. (2018). Thermal analysis of ice and glass transitions in insects that do and do not survive freezing. J. Exp. Biol. 221 :jeb170464 .
Rudolph A. S. Crowe J. H. (1985). Membrane stabilization during freezing: the role of two natural cryoprotectants, trehalose and proline. Cryobiology 22 367–377. 10.1016/0011-2240(85)90184-1 4028782
Runti G. Lopez Ruiz, Mdel C. Stoilova T. Hussain R. Jennions M. (2013). Functional characterization of SbmA, a bacterial inner membrane transporter required for importing the antimicrobial peptide Bac7(1-35). J. Bacteriol. 195 5343–5351. 10.1128/jb.00818-13 24078610
Ryter S. W. Cloonan S. M. Choi A. M. (2013). Autophagy: a critical regulator of cellular metabolism and homeostasis. Mol. Cells 36 7–16. 10.1007/s10059-013-0140-8 23708729
Sabi R. Tuller T. (2015). A comparative genomics study on the effect of individual amino acids on ribosome stalling. BMC Genomics 16 (Suppl. 10) :S5 . 10.1186/1471-2164-16-S10-S5 26449596
Sahu N. Dela Cruz D. Gao M. Sandoval W. Haverty P. M. Liu J. (2016). Proline starvation induces unresolved ER stress and hinders mTORC1-Dependent tumorigenesis. Cell Metab. 24 753–761. 10.1016/j.cmet.2016.08.008 27618686
Samuel D. Kumar T. K. Ganesh G. Jayaraman G. Yang P. W. Chang M. M. (2000). Proline inhibits aggregation during protein refolding. Protein Sci. 9 344–352. 10.1110/ps.9.2.344 10716186
Samuel D. Kumar T. K. Jayaraman G. Yang P. W. Yu C. (1997). Proline is a protein solubilizing solute. Biochem. Mol. Biol. Int. 41 235–242. 10.1080/15216549700201241 9063563
Sanchez-Partida L. G. Setchell B. P. Maxwell W. M. (1998). Effect of compatible solutes and diluent composition on the post-thaw motility of ram sperm. Reprod. Fertil. Dev. 10 347–357. 10.1071/r98053 10355687
Sandoval D. R. Clausen T. M. Nora C. Cribbs A. P. Denardo A. Clark A. E. (2021). The Prolyl-tRNA synthetase inhibitor halofuginone inhibits SARS-CoV-2 infection. bioRxiv [preprint] 10.1101/2021.03.22.436522 33791697
Sasahira T. Kurihara-Shimomura M. Shimomura H. Bosserhoff A. K. Kirita T. (2021). Identification of oral squamous cell carcinoma markers MUC2 and SPRR1B downstream of TANGO. J. Cancer Res. Clin. Oncol. 147 1659–1672. 10.1007/s00432-021-03568-9 33620575
Saye M. Fargnoli L. Reigada C. Labadie G. R. Pereira C. A. (2017). Evaluation of proline analogs as trypanocidal agents through the inhibition of a proline transporter. Biochim. Biophys. Acta 1861 2913–2921. 10.1016/j.bbagen.2017.08.015 28844978
Scaraffia P. Y. Wells M. A. (2003). Proline can be utilized as an energy substrate during flight of Aedes aegypti females. J. Insect Physiol. 49 591–601. 10.1016/s0022-1910(03)00031-3 12804719
Schafer I. A. Scriver C. R. Efron M. L. (1962). Familial hyperprolinemia, cerebral dysfunction and renal anomalies occurring in a family with hereditary nephropathy and deafness. N. Engl. J. Med. 267 51–60. 10.1056/nejm196207122670201 14497974
Scheres B. Van De Wiel C. Zalensky A. Horvath B. Spaink H. Van Eck H. (1990). The ENOD12 gene product is involved in the infection process during the pea-Rhizobium interaction. Cell 60 281–294. 10.1016/0092-8674(90)90743-x 2297789
Schulz D. Morschel J. Schuster S. Eulenburg V. Gomeza J. (2018). Inactivation of the mouse L-Proline transporter PROT alters glutamatergic synapse biochemistry and perturbs behaviors required to respond to environmental changes. Front. Mol. Neurosci. 11 :279 . 10.3389/fnmol.2018.00279 30177871
Scriver C. R. (1968). Renal tubular transport of proline, hydroxyproline, and glycine. 3. genetic basis for more than one mode of transport in human kidney. J. Clin. Invest. 47 823–835. 10.1172/jci105776 5641621
Seefeldt A. C. Graf M. Perebaskine N. Nguyen F. Arenz S. Mardirossian M. (2016). Structure of the mammalian antimicrobial peptide Bac7(1-16) bound within the exit tunnel of a bacterial ribosome. Nucleic Acids Res. 44 2429–2438. 10.1093/nar/gkv1545 26792896
Seefeldt A. C. Nguyen F. Antunes S. Perebaskine N. Graf M. Arenz S. (2015). The proline-rich antimicrobial peptide Onc112 inhibits translation by blocking and destabilizing the initiation complex. Nat. Struct. Mol. Biol. 22 470–475. 10.1038/nsmb.3034 25984971
Seow H. F. Broer S. Broer A. Bailey C. G. Potter S. J. Cavanaugh J. A. (2004). Hartnup disorder is caused by mutations in the gene encoding the neutral amino acid transporter SLC6A19. Nat. Genet. 36 1003–1007. 10.1038/ng1406 15286788
Seri M. Cusano R. Forabosco P. Cinti R. Caroli F. Picco P. (1999). Genetic mapping to 10q23.3-q24.2, in a large Italian pedigree, of a new syndrome showing bilateral cataracts, gastroesophageal reflux, and spastic paraparesis with amyotrophy. Am. J. Hum. Genet. 64 586–593. 10.1086/302241 9973297
Servet C. Ghelis T. Richard L. Zilberstein A. Savoure A. (2012). Proline dehydrogenase: a key enzyme in controlling cellular homeostasis. Front. Biosci. (Landmark Ed) 17 :607–620. 10.2741/3947 22201764
Shafqat S. Velaz-Faircloth M. Henzi V. A. Whitney K. D. Yang-Feng T. L. Seldin M. F. (1995). Human brain-specific L-proline transporter: molecular cloning, functional expression, and chromosomal localization of the gene in human and mouse genomes. Mol. Pharmacol. 48 219–229.7651355
Shamova O. Brogden K. A. Zhao C. Nguyen T. Kokryakov V. N. Lehrer R. I. (1999). Purification and properties of proline-rich antimicrobial peptides from sheep and goat leukocytes. Infect. Immun. 67 4106–4111. 10.1128/iai.67.8.4106-4111.1999 10417180
Sharif T. Dai C. Martell E. Ghassemi-Rad M. S. Hanes M. R. Murphy P. J. (2019). TAp73 modifies metabolism and positively regulates growth of cancer stem-like cells in a redox-sensitive manner. Clin. Cancer Res. 25 2001–2017. 10.1158/1078-0432.ccr-17-3177 30593514
Sharma S. S. Schat H. Vooijs R. (1998). In vitro alleviation of heavy metal-induced enzyme inhibition by proline. Phytochemistry 49 1531–1535. 10.1016/s0031-9422(98)00282-9 11711061
Sherrier D. J. Taylor G. S. Silverstein K. A. Gonzales M. B. Vandenbosch K. A. (2005). Accumulation of extracellular proteins bearing unique proline-rich motifs in intercellular spaces of the legume nodule parenchyma. Protoplasma 225 43–55. 10.1007/s00709-005-0090-x 15868212
Shi X. Z. Zhao X. F. Wang J. X. (2014). A new type antimicrobial peptide astacidin functions in antibacterial immune response in red swamp crayfish Procambarus clarkii. Dev. Comp. Immunol. 43 121–128. 10.1016/j.dci.2013.11.003 24263004
Showalter A. M. (1993). Structure and function of plant cell wall proteins. Plant Cell 5 9–23. 10.2307/3869424 8439747
Signorelli S. (2016). The fermentation analogy: a point of view for understanding the intriguing role of proline accumulation in stressed plants. Front. Plant Sci. 7 :1339 . 10.3389/fpls.2016.01339 27642286
Silao F. G. S. Ward M. Ryman K. Wallstrom A. Brindefalk B. Udekwu K. (2019). Mitochondrial proline catabolism activates Ras1/cAMP/PKA-induced filamentation in Candida albicans. PLoS Genet. 15 :e1007976 . 10.1371/journal.pgen.1007976 30742618
Skidmore D. L. Chitayat D. Morgan T. Hinek A. Fischer B. Dimopoulou A. (2011). Further expansion of the phenotypic spectrum associated with mutations in ALDH18A1, encoding Delta(1)-pyrroline-5-carboxylate synthase (P5CS). Am. J. Med. Genet. A 155A 1848–1856. 10.1002/ajmg.a.34057 21739576
Slavotinek A. M. Pike M. Mills K. Hurst J. A. (1996). Cataracts, motor system disorder, short stature, learning difficulties, and skeletal abnormalities: a new syndrome? Am. J. Med. Genet. 62 42–47. 10.1002/(sici)1096-8628(19960301)62:1<42::aid-ajmg9>3.0.co;2-y 8779323
Smith K. Rennie M. J. (2007). New approaches and recent results concerning human-tissue collagen synthesis. Curr. Opin. Clin. Nutr. Metab. Care 10 582–590. 10.1097/mco.0b013e328285d858 17693741
Smith T. K. Bringaud F. Nolan D. P. Figueiredo L. M. (2017). Metabolic reprogramming during the Trypanosoma brucei life cycle. F1000Res 6 :F1000FacultyRev-683 .
Stadmiller S. S. Gorensek-Benitez A. H. Guseman A. J. Pielak G. J. (2017). Osmotic shock induced protein destabilization in living cells and its reversal by glycine betaine. J. Mol. Biol. 429 1155–1161. 10.1016/j.jmb.2017.03.001 28263768
Steinert P. M. Candi E. Kartasova T. Marekov L. (1998a). Small proline-rich proteins are cross-bridging proteins in the cornified cell envelopes of stratified squamous epithelia. J. Struct. Biol. 122 76–85. 10.1006/jsbi.1998.3957 9724607
Steinert P. M. Kartasova T. Marekov L. N. (1998b). Biochemical evidence that small proline-rich proteins and trichohyalin function in epithelia by modulation of the biomechanical properties of their cornified cell envelopes. J. Biol. Chem. 273 11758–11769. 10.1074/jbc.273.19.11758 9565599
Stensvag K. Haug T. Sperstad S. V. Rekdal O. Indrevoll B. Styrvold O. B. (2008). Arasin 1, a proline-arginine-rich antimicrobial peptide isolated from the spider crab, Hyas araneus. Dev. Comp. Immunol. 32 275–285. 10.1016/j.dci.2007.06.002 17658600
Stetina T. Hula P. Moos M. Simek P. Smilauer P. Kostal V. (2018). Recovery from supercooling, freezing, and cryopreservation stress in larvae of the drosophilid fly. Chymomyza costata. Sci. Rep. 8 :4414 .
Stromberg N. Esberg A. Sheng N. Marell L. Lofgren-Burstrom A. Danielsson K. (2017). Genetic- and lifestyle-dependent dental caries defined by the acidic proline-rich protein genes PRH1 and PRH2. EBioMedicine 26 38–46. 10.1016/j.ebiom.2017.11.019 29191562
Sun C. Li T. Song X. Huang L. Zang Q. Xu J. (2019). Spatially resolved metabolomics to discover tumor-associated metabolic alterations. Proc. Natl. Acad. Sci. U S A. 116 52–57. 10.1073/pnas.1808950116 30559182
Sun H. Glasmacher B. Hofmann N. (2012). Compatible solutes improve cryopreservation of human endothelial cells. Cryo. Lett. 33 485–493.
Surguchov A. Bernal L. Surguchev A. A. (2021). Phytochemicals as regulators of genes involved in synucleinopathies. Biomolecules 11 :624 . 10.3390/biom11050624 33922207
Szabados L. Savoure A. (2010). Proline: a multifunctional amino acid. Trends Plant Sci. 15 89–97. 10.1016/j.tplants.2009.11.009 20036181
Takagi H. (2008). Proline as a stress protectant in yeast: physiological functions, metabolic regulations, and biotechnological applications. Appl. Microbiol. Biotechnol. 81 211–223. 10.1007/s00253-008-1698-5 18802692
Tan B. S. Lonic A. Morris M. B. Rathjen P. D. Rathjen J. (2011). The amino acid transporter SNAT2 mediates L-proline-induced differentiation of ES cells. Am. J. Physiol. Cell Physiol. 300 C1270–C1279.21346154
Tancredi F. Guazzi G. Auricchio S. (1970). Renal iminoglycinuria without intestinal malabsorption of glycine and imino acids. J. Pediatr. 76 386–392. 10.1016/s0022-3476(70)80477-2 5308714
Taniguchi M. Ochiai A. Kondo H. Fukuda S. Ishiyama Y. Saitoh E. (2016). Pyrrhocoricin, a proline-rich antimicrobial peptide derived from insect, inhibits the translation process in the cell-free Escherichia coli protein synthesis system. J. Biosci. Bioeng. 121 591–598. 10.1016/j.jbiosc.2015.09.002 26472128
Tanner J. J. Fendt S. M. Becker D. F. (2018). The proline cycle as a potential cancer therapy target. Biochemistry 57 3433–3444. 10.1021/acs.biochem.8b00215 29648801
Teulier L. Weber J. M. Crevier J. Darveau C. A. (2016). Proline as a fuel for insect flight: enhancing carbohydrate oxidation in hymenopterans. Proc. Biol. Sci. 283 :20160333 . 10.1098/rspb.2016.0333 27412285
Theillet F. X. Kalmar L. Tompa P. Han K. H. Selenko P. Dunker A. K. (2013). The alphabet of intrinsic disorder: I. act like a Pro: on the abundance and roles of proline residues in intrinsically disordered proteins. Intrinsically Disord Proteins 1 :e24360 . 10.4161/idp.24360 28516008
Thiemicke A. Neuert G. (2021). Kinetics of osmotic stress regulate a cell fate switch of cell survival. Sci. Adv. 7 :eabe1122 . 10.1126/sciadv.abe1122 33608274
Thwaites D. T. Anderson C. M. (2007). Deciphering the mechanisms of intestinal imino (and amino) acid transport: the redemption of SLC36A1. Biochim. Biophys. Acta 1768 179–197. 10.1016/j.bbamem.2006.10.001 17123464
Thwaites D. T. Anderson C. M. (2011). The SLC36 family of proton-coupled amino acid transporters and their potential role in drug transport. Br. J. Pharmacol. 164 1802–1816. 10.1111/j.1476-5381.2011.01438.x 21501141
Tomlinson C. Rafii M. Ball R. O. Pencharz P. B. (2011a). Arginine can be synthesized from enteral proline in healthy adult humans. J. Nutr. 141 1432–1436. 10.3945/jn.110.137224 21677074
Tomlinson C. Rafii M. Sgro M. Ball R. O. Pencharz P. (2011b). Arginine is synthesized from proline, not glutamate, in enterally fed human preterm neonates. Pediatr. Res. 69 46–50. 10.1203/pdr.0b013e3181fc6ab7 20856169
Town B. W. (1928). The isolation of pure l-proline. Biochem. J. 22 1083–1086. 10.1042/bj0221083 16744102
Tran D. H. Kesavan R. Rion H. Soflaee M. H. Solmonson A. Bezwada D. (2021). Mitochondrial NADP(+) is essential for proline biosynthesis during cell growth. Nat. Metab. 3 571–585. 10.1038/s42255-021-00374-y 33833463
Treleaven T. Hardy M. L. M. Guttman-Jones M. Morris M. B. Day M. L. (2021). In vitro fertilisation of mouse oocytes in L-Proline and L-Pipecolic acid improves subsequent development. Cells 10 :1352 . 10.3390/cells10061352 34072568
Trovato M. Maras B. Linhares F. Costantino P. (2001). The plant oncogene rolD encodes a functional ornithine cyclodeaminase. Proc. Natl. Acad. Sci. U S A. 98 13449–13453. 10.1073/pnas.231320398 11687622
Trovato M. Mattioli R. Costantino P. (2018). From A. rhizogenes RolD to plant P5CS: exploiting proline to control plant development. Plants (Basel) 7 :108 . 10.3390/plants7040108 30563242
Tugnoli B. Bernardini C. Forni M. Piva A. Stahl C. H. Grilli E. (2019). Butyric acid induces spontaneous adipocytic differentiation of porcine bone marrow-derived mesenchymal stem cells. Vitro Cell Dev. Biol. Anim. 55 17–24. 10.1007/s11626-018-0307-x 30456456
Ugwu D. I. Okoro U. C. Mishra N. K. (2018). Synthesis of proline derived benzenesulfonamides: a potent anti-Trypanosoma brucei gambiense agent. Eur. J. Med. Chem. 154 110–116. 10.1016/j.ejmech.2018.05.017 29778893
Valle D. Goodman S. I. Applegarth D. A. Shih V. E. Phang J. M. (1976). Type II hyperprolinemia. Delta1-pyrroline-5-carboxylic acid dehydrogenase deficiency in cultured skin fibroblasts and circulating lymphocytes. J. Clin. Invest. 58 598–603. 10.1172/jci108506 956388
Valle D. L. Phang J. M. Goodman S. I. (1974). Type 2 hyperprolinemia: absence of delta1-pyrroline-5-carboxylic acid dehydrogenase activity. Science 185 1053–1054. 10.1126/science.185.4156.1053 4369405
Velasquez S. M. Ricardi M. M. Dorosz J. G. Fernandez P. V. Nadra A. D. Pol-Fachin L. (2011). O-glycosylated cell wall proteins are essential in root hair growth. Science 332 1401–1403. 10.1126/science.1206657 21680836
Velaz-Faircloth M. Guadano-Ferraz A. Henzi V. A. Fremeau R. T. Jr. (1995). Mammalian brain-specific L-proline transporter. neuronal localization of mRNA and enrichment of transporter protein in synaptic plasma membranes. J. Biol. Chem. 270 15755–15761. 10.1074/jbc.270.26.15755 7797577
Verbruggen N. Hermans C. (2008). Proline accumulation in plants: a review. Amino Acids 35 753–759. 10.1007/s00726-008-0061-6 18379856
Verrey F. Singer D. Ramadan T. Vuille-Dit-Bille R. N. Mariotta L. Camargo S. M. (2009). Kidney amino acid transport. Pflugers. Arch. 458 53–60.19184091
Verslues P. E. Sharma S. (2010). Proline metabolism and its implications for plant-environment interaction. Arabidopsis Book 8 :e0140 . 10.1199/tab.0140 22303265
Villafraz O. Biran M. Pineda E. Plazolles N. Cahoreau E. Ornitz Oliveira (2021). Procyclic trypanosomes recycle glucose catabolites and TCA cycle intermediates to stimulate growth in the presence of physiological amounts of proline. PLoS Pathog 17 :e1009204 . 10.1371/journal.ppat.1009204 33647053
Wachter R. Langhans M. Aloni R. Gotz S. Weilmunster A. Koops A. (2003). Vascularization, high-volume solution flow, and localized roles for enzymes of sucrose metabolism during tumorigenesis by Agrobacterium tumefaciens. Plant Physiol. 133 1024–1037. 10.1104/pp.103.028142 14526106
Wang A. Bolen D. W. (1996). Effect of proline on lactate dehydrogenase activity: testing the generality and scope of the compatibility paradigm. Biophys. J. 71 2117–2122. 10.1016/s0006-3495(96)79410-9 8889186
Washington J. M. Rathjen J. Felquer F. Lonic A. Bettess M. D. Hamra N. (2010). L-Proline induces differentiation of ES cells: a novel role for an amino acid in the regulation of pluripotent cells in culture. Am. J. Physiol. Cell Physiol. 298 C982–C992.20164384
Weinberger B. Hanna N. Laskin J. D. Heck D. E. Gardner C. R. Gerecke D. R. (2005). Mechanisms mediating the biologic activity of synthetic proline, glycine, and hydroxyproline polypeptides in human neutrophils. Mediators Inflamm. 2005 31–38. 10.1155/mi.2005.31 15770064
Werneck R. I. Mira M. T. Trevilatto P. C. (2010). A critical review: an overview of genetic influence on dental caries. Oral. Dis. 16 613–623. 10.1111/j.1601-0825.2010.01675.x 20846151
White F. F. Taylor B. H. Huffman G. A. Gordon M. P. Nester E. W. (1985). Molecular and genetic analysis of the transferred DNA regions of the root-inducing plasmid of Agrobacterium rhizogenes. J. Bacteriol. 164 33–44. 10.1128/jb.164.1.33-44.1985 4044524
Wiesenthal A. A. Muller C. Harder K. Hildebrandt J. P. (2019). Alanine, proline and urea are major organic osmolytes in the snail Theodoxus fluviatilis under hyperosmotic stress. J. Exp. Biol. 222 (Pt 3) :jeb193557 .
Wondrak G. T. Jacobson M. K. Jacobson E. L. (2005). Identification of quenchers of photoexcited States as novel agents for skin photoprotection. J. Pharmacol. Exp. Ther. 312 482–491. 10.1124/jpet.104.075101 15475591
Wu G. Bazer F. W. Datta S. Johnson G. A. Li P. Satterfield M. C. (2008). Proline metabolism in the conceptus: implications for fetal growth and development. Amino Acids 35 691–702. 10.1007/s00726-008-0052-7 18330497
Wu G. Bazer F. W. Hu J. Johnson G. A. Spencer T. E. (2005). Polyamine synthesis from proline in the developing porcine placenta. Biol. Reprod. 72 842–850. 10.1095/biolreprod.104.036293 15576824
Wu H. De Graaf B. Mariani C. Cheung A. Y. (2001). Hydroxyproline-rich glycoproteins in plant reproductive tissues: structure, functions and regulation. Cell Mol. Life. Sci. 58 1418–1429. 10.1007/pl00000785 11693523
Wu J. Subbaiah K. C. V. Xie L. H. Jiang F. Khor E. S. Mickelsen D. (2020). Glutamyl-Prolyl-tRNA synthetase regulates proline-rich pro-fibrotic protein synthesis during cardiac fibrosis. Circ. Res. 127 827–846. 10.1161/circresaha.119.315999 32611237
Wyse A. T. Netto C. A. (2011). Behavioral and neurochemical effects of proline. Metab. Brain Dis. 26 159–172. 10.1007/s11011-011-9246-x 21643764
Xie Z. Klionsky D. J. (2007). Autophagosome formation: core machinery and adaptations. Nat. Cell Biol. 9 1102–1109. 10.1038/ncb1007-1102 17909521
Yam M. Engel A. L. Wang Y. Zhu S. Hauer A. Zhang R. (2019). Proline mediates metabolic communication between retinal pigment epithelial cells and the retina. J. Biol. Chem. 294 10278–10289. 10.1074/jbc.ra119.007983 31110046
Yamaguchi M. Shiraishi T. Hirama M. (1996). Asymmetric michael addition of malonate anions to prochiral acceptors catalyzed by L-proline rubidium salt. J. Org. Chem. 61 3520–3530. 10.1021/jo960216c
Yang S. L. Lan S. S. Gong M. (2009). Hydrogen peroxide-induced proline and metabolic pathway of its accumulation in maize seedlings. J. Plant Physiol. 166 1694–1699. 10.1016/j.jplph.2009.04.006 19446917
Ye Y. Wu Y. Wang J. (2018). Pyrroline-5-carboxylate reductase 1 promotes cell proliferation via inhibiting apoptosis in human malignant melanoma. Cancer Manag. Res. 10 6399–6407. 10.2147/cmar.s166711 30568501
Yen C. A. Curran S. P. (2021). Incomplete proline catabolism drives premature sperm aging. Aging Cell 20 :e13308 .
Yoon S. C. Jang Y. L. Kim J. W. Cho E. Y. Park D. Y. Hong K. S. (2016). Linkage and association analyses of schizophrenia with genetic variations on chromosome 22q11 in Koreans. Psychiatry Investig. 13 630–636. 10.4306/pi.2016.13.6.630 27909454
Yoshiba Y. Kiyosue T. Nakashima K. Yamaguchi-Shinozaki K. Shinozaki K. (1997). Regulation of levels of proline as an osmolyte in plants under water stress. Plant Cell Physiol. 38 1095–1102. 10.1093/oxfordjournals.pcp.a029093 9399433
Zaki M. S. Bhat G. Sultan T. Issa M. Jung H. J. Dikoglu E. (2016). PYCR2 mutations cause a lethal syndrome of microcephaly and failure to thrive. Ann. Neurol. 80 59–70. 10.1002/ana.24678 27130255
Zaprasis A. Brill J. Thuring M. Wunsche G. Heun M. Barzantny H. (2013). Osmoprotection of Bacillus subtilis through import and proteolysis of proline-containing peptides. Appl. Environ. Microbiol. 79 576–587. 10.1128/aem.01934-12 23144141
Zarse K. Schmeisser S. Groth M. Priebe S. Beuster G. Kuhlow D. (2012). Impaired insulin/IGF1 signaling extends life span by promoting mitochondrial L-proline catabolism to induce a transient ROS signal. Cell Metab. 15 451–465. 10.1016/j.cmet.2012.02.013 22482728
Zdunek-Zastocka E. Grabowska A. Michniewska B. Orzechowski S. (2021). Proline concentration and its metabolism are regulated in a leaf age dependent manner but not by abscisic acid in pea plants exposed to cadmium stress. Cells 10 :946 . 10.3390/cells10040946 33923901
Zeng T. Zhu L. Liao M. Zhuo W. Yang S. Wu W. (2017). Knockdown of PYCR1 inhibits cell proliferation and colony formation via cell cycle arrest and apoptosis in prostate cancer. Med. Oncol. 34 :27 .
Zhang L. Alfano J. R. Becker D. F. (2015). Proline metabolism increases katG expression and oxidative stress resistance in Escherichia coli. J. Bacteriol. 197 431–440. 10.1128/jb.02282-14 25384482
Zhang L. Xue X. Yan J. Yan L. Y. Jin X. H. Zhu X. H. (2016a). Cryobiological characteristics of L-proline in mammalian oocyte cryopreservation. Chin. Med. J. (Engl) 129 1963–1968. 10.4103/0366-6999.187846 27503023
Zhang L. Xue X. Yan J. Yan L. Y. Jin X. H. Zhu X. H. (2016b). L-proline: a highly effective cryoprotectant for mouse oocyte vitrification. Sci. Rep. 6 :26326 .
Zhang P. Wang J. Luo W. Yuan J. Cui C. Guo L. (2021a). Kindlin-2 acts as a key mediator of lung fibroblast activation and pulmonary fibrosis progression. Am. J. Respir. Cell Mol. Biol. 65 54–69. 10.1165/rcmb.2020-0320oc 33761308
Zhang X. Gong X. Li D. Yue H. Qin Y. Liu Z. (2021b). Genome-Wide identification of PRP genes in apple genome and the role of MdPRP6 in response to heat stress. Int. J. Mol. Sci. 22 :5942 . 10.3390/ijms22115942 34073055
Zhu J. Schworer S. Berisa M. Kyung Y. J. Ryu K. W. Yi J. (2021). Mitochondrial NADP(H) generation is essential for proline biosynthesis. Science 372 968–972. 10.1126/science.abd5491 33888598
Zipp G. G. Barbosa J. Green M. A. Terranova K. M. Fink C. Yu X. C. (2014). Novel inhibitors of the high-affinity L-proline transporter as potential therapeutic agents for the treatment of cognitive disorders. Bioorg. Med. Chem. Lett. 24 3886–3890. 10.1016/j.bmcl.2014.06.049 25037917
Zouari M. Ben Ahmed C. Elloumi N. Bellassoued K. Delmail D. Labrousse P. (2016). Impact of proline application on cadmium accumulation, mineral nutrition and enzymatic antioxidant defense system of Olea europaea L. cv Chemlali exposed to cadmium stress. Ecotoxicol. Environ. Saf. 128 195–205. 10.1016/j.ecoenv.2016.02.024 26946284
Zwarts L. Vulsteke V. Buhl E. Hodge J. J. L. Callaerts P. (2017). SlgA, encoded by the homolog of the human schizophrenia-associated gene PRODH, acts in clock neurons to regulate Drosophila aggression. Dis. Model. Mech. 10 705–716.28331058

